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ABSTRACT
The human body consists of approximately 30 trillion cells, while non-human microbes
that reside on and within the body outnumber human somatic cells by a factor of 1.3 – 2.3. The
interplay between our cells and those of the colonizing microorganisms affect physiology in a
multitude of ways, both beneficial and detrimental. Microbes found in the oral cavity, such as the
Red Complex member Porphyromonas gingivalis, are associated with pathology, namely
periodontal diseases including gum deterioration, tooth decay, and loss of underlying alveolar
bone. At the other end of the gastrointestinal tract, microbes such as Bacteroides thetaiotaomicron
are found in abundance in the distal intestine and form symbiotic relationships that are critical for
the proper function of the mammalian colon. Carbohydrates are integral for the survival of both of
these organisms; as sources of energy, physical anchors, and barriers against environmental stress.
As such, these microbes present interesting models for the study of extremely important hostmicrobial relationships involving carbohydrates and pathologic or beneficial mechanisms in
carbohydrate metabolism.
The successful expression and purification of four homologous putative galactosidases
from B. thetaiotaomicron, BT2109, BT2918, BT2966, and BT3158 are reported, along with
BT2857, which has been expressed and purified previously. Crystallization and X-ray diffraction
analyses of three of these full-length galactosidases was achieved, along with two truncations of
BT2857 and one of BT3158. Functional kinetic characterization and generation of MichaelisMenten

constants

was

conducted

using

the

galactose

analogs

para-nitrophenyl-β-

galactopyranoside and para-nitrophenyl-α-galactopyranoside. Thin layer-chromatographic
analysis using a variety of galactose-containing oligo/poly-saccharides was used to analyze
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degradative capability of these enzymes, along with nuclear magnetic resonance and mass
spectrometric analysis to characterize the products of these degradative reactions.
The expression and purification of three proteins from P. gingivalis, PGN1176 (a shortchain fatty-acid dehydrogenase), PGN1459 (a putative DNA-defense and mutagenic protein), and
PGN1461 (a putative spore-maturation protein, researched in collaboration with Katarina Mandić)
are reported. Crystallization and preliminary X-ray diffraction of all three proteins was completed.
Preliminary functional characterization of two proteins, PGN1459 and PGN1461, was conducted
using a crude DNA-shift assay and thin-layer chromatographic analysis against a diverse array of
(poly)saccharides, respectively.
Crystallization, diffraction, structural determination, and functional definition of each of
these proteins is of critical importance in gaining insight into the roles these proteins play in either
the symbiotic or pathogenic relationships between the human body and the resident organisms of
the microbiome.
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CHAPTER 1 - INTRODUCTION
1.1

Carbohydrates, Metabolic Chemistry, and Prokaryotes
Carbohydrates, also frequently referred to as either saccharides or, informally, sugars, are

a type of biomolecule found in all cells in every kingdom of life (1). These molecules, ranging in
size from single monosaccharide units to polysaccharides consisting of thousands of
monosaccharide subunits, are involved in a multitude of biochemical processes and structural roles
(2). This class of compounds can also be decorated with a variety of functional groups and serve
as functional conjugates for other non-saccharide macro- or small-molecules(3, 4). Because of this
enormous diversity, carbohydrates are thus ubiquitous in cells, and are essential to the metabolism
and survival of any living organism (5). In these cellular locations carbohydrates can be found
serving roles such as extra-/inter-cellular structure and communication (6), energy storage and
transport (7), serving as the backbone for DNA (8), functionalization through glycosylation of
proteins and lipids (9, 10), cell adhesion and biofilm formation (11, 12), and cellular protection
(13, 14). The wide variety of functions played by carbohydrates in cellular processes makes these
biomolecules, and the macromolecules that interact with them, a highly relevant area of study. Of
particular interest in this study are how specific prokaryotes rely on carbohydrate biochemistry as
the metabolism of these macromolecules is the preferred avenue of energy production for the vast
majority of bacteria(15, 16). Polysaccharides produced and consumed by bacteria are far more
varied than those of other organisms: complex carbohydrates produced by this class of organisms
are approximately 10-fold and 9-fold more diverse than mammalian glycans at monosaccharide
and disaccharide levels, respectively(17), and certain species have been seen to be able to live on
the most complex polysaccharide yet known(18). The plethora of catalytic and non-catalytic

1

interactions prokaryotes have with carbohydrates include two groups of proteins: carbohydrateactive enzymes and carbohydrate-binding modules, respectively.
1.2

Carbohydrate-Active Enzymes and Carbohydrate-Binding Modules
Carbohydrate-active enzymes (CAZymes) are defined as any enzyme or enzymatic domain

capable of acting on a carbohydrate substrate for either breakdown, synthesis, or modification(19).
As of August 2019, the Carbohydrate-Active Enzyme Database (www.cazy.org) contains
information on 165 glycoside hydrolases, 107 glycosyltransferases, 37 polysaccharide lyases, 16
carbohydrate esterases, and 16 auxiliary activity enzymes(20). Glycoside hydrolases breakdown
glycosidic bonds between saccharide residues, or between a saccharide residue and a nonsaccharide moiety, typically with a Koshland-style mechanism utilizing a nucleophilic amino acid
general acid/base amino acid as the catalytic residues(21, 22). Glycosyltransferases function as the
builders of oligo-/poly-saccharide, forming glycosidic bonds between an activated donor
saccharide (containing a nucleotide- or lipid-phosphate leaving group) and a specific acceptor
molecule(23, 24). Polysaccharide lyase enzymes cleave glycosidic bonds in polysaccharide chains
that contain uronic acid saccharides (sugars with both carboxylic acid and carbonyl functional
groups) via β-elimination, yielding a saturated and unsaturated hexenuronic acid product(25).
Carbohydrate esterase enzymes catalyze to removal of O- and N-acetyl groups on substituted
saccharides, and a number of different mechanisms may be utilized(26). The auxiliary activity
group of CAZymes are unique in that members of this family contain lytic redox
enzymes/enzymatic domains that break-down polysaccharides such as cellulose, and in some cases
the complex organic polymer lignin(27). The database has also classified 85 distinct types of
carbohydrate-binding module: a domain, typically appended to enzymatic domains within a larger
protein sequence, that can bind saccharide substrates but on their own lack catalytic activity(28).
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CAZymes are distinguished from one another and grouped into families on the basis of primary
sequence and structural similarity, rather than by substrate specificity or mechanism of action(29).
Due to the method of grouping utilized for CAZymes, substrate specificity, catalytic mechanisms,
and kinetic profiles may vary quite a bit even between enzymes that belong to the same family.
Thus, biochemical characterization is needed to truly determine the functional character of any
CAZyme(30). Characterization, both structurally and functionally, of CAZymes is critical to
understanding the litany of carbohydrate and carbohydrate-related processes and interactions
within the biosphere, understanding which can be applied to fields such as agriculture, biofuel
production, and medicine(31).
1.3

The Human Microbiome
The human microbiome is defined as the collection of all organisms, symbiotic,

commensal, and pathogenic, that reside within and on the human body(32). Interest in the human
microbiome has increased drastically since the publication of the initial draft of the human genome
by the International Human Genome Sequencing Consortium in 2001(33) as the role this collection
of organisms plays in human health has become more and more apparent(34). The initial estimates
for the number of protein products the human genome encoded for were between 70,000 and
100,000 based on the number of biological functions necessary to maintain life as well as
extrapolation from CpG island counts in previously sequenced gene fragments and the frequency
with which they are associated with known genes(35, 36). After the completion of the Human
Genome Project, a new estimate of 30,000 - 40,000 genes was made, and the current estimate has
decreased that to only 21,306 protein-coding genes(37). Many of the microorganisms that
constitute the human microbiome help to make up for this apparent functional metabolic deficit in
the human genome(38). Only recently have biotechnological tools and techniques allowing for the
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study of the complex microbial communities that make up the human microbiome been developed,
studies which have revealed that gaps in the current understanding of host-microbial interactions
are larger than previously thought(39). These complex microbial communities that make up the
microbiome are not uniformly dispersed, but rather clustered in certain sections of the human body,
such as the intestinal tract and oral cavity(40). Collectively, these microbial clusters house trillions
of microorganisms representing thousands of different species and strains, with these organisms
estimated to outnumber human cells by a factor of 1.3 - 2.3(41, 42). Many of the organisms have
also been identified as abundant sources of CAZymes, enabling them to survive in the unique
polymicrobial environments which they are found in(43, 44). Some of these organisms may
dedicate up to 6% of their genome to coding for CAZymes, a significant increase over the typical
1 – 2% seen in other organisms(45). Being so numerous and playing such a prominent role in
human physiology, characterizing the genomes of these organisms and protein products for which
they encode is essential to further the understanding of human-microbiota relationships, as well as
providing a source of novel CAZymes for potential application in biotechnology and industry(46).
1.4

Bacteroides thetaiotaomicron and the Gut Microbiome
The human gut microflora is a diverse group of microorganisms that live within the

intestinal tract(47). The ecology of this particular microflora is affected by several factors such as
age, diet, and host genotype(48). Bacteroides thetaiotaomicron is a major component of this group,
accounting for a total of 6% of all microorganisms and 12% of all Bacteroides species in the distal
intestinal tract, by population(49). B. thetaiotaomicron and other mutualistic organisms within the
gut, play several roles in regulating the proper function of the intestine, including: formation and
maintenance of the protective mucosal barrier, enhancement of nutrient absorption, host immune
activation, and stimulation of the local circulatory system(50–52). Previous studies involving the

4

colonization of germ-free mice with B. thetaiotaomicron illustrated in vivo how critical the
organism, and indeed the rest of gut microflora, are to proper physiology, with mice experiencing
fold increases in host expression between 2.6 and 205 of multiple protein markers associated with
colonic health following colonization(53). Mice with a healthy microflora also required 30% fewer
calories to maintain body weight compared to their germ-free counterparts(54). Short-chain fatty
acids produced by gut microbes through fermentation of undigested carbohydrates is estimated to
contribute up to 10% of a person’s daily calories, depending on the composition of an individual’s
diet and microbiome(55). In addition to being vital for the proper expression of host gene products,
the intestinal (and human) microflora contributes a great deal of metabolic functionality, making
up for the deficit in the human genome(38). B. thetaiotaomicron is one of the only organisms know
to be capable of surviving on exclusively the most complicated carbohydrate known,
rhamnogalacturonan-II, thanks to its large array of CAZyme and CAZyme-related genes(18). The
degradation, modification, transportation, and formation of carbohydrates by B. thetaiotaomicron
is strictly controlled, and CAZymes are organized into discreet clusters on the genome known as
polysaccharide utilized loci(56).
1.4.1 Polysaccharide Utilization Loci and the B. thetaiotaomicron Genome
The tightly regulated linear clusters of genes known as Polysaccharide Utilization Loci
(PULs) are found throughout the genome of B. thetaiotaomicron(57). A PUL is a single gene locus
which contains all genes necessary for the association with a polysaccharide at the cell surface, the
subsequent processing of this polysaccharide into large oligosaccharides, followed by the
importation of these oligosaccharides into the periplasmic space and/or cytoplasm, and lastly, the
degradation of the oligosaccharides into monosaccharide components. Each PUL also contains a
regulatory gene necessary for modulation of its activity(58). The VPI-5482 B. thetaiotaomicron

5

strain contains a total of 88 of these utilization loci, encoding for a total of 866 genes and making
up 18% of the genome(59). Of the organisms that comprise the human microflora, and in fact all
organisms, the genome of B. thetaiotaomicron codes for the expression of the largest number of
CAZymes; comprising 279 glycoside hydrolases, 87 glycoside transferases, 15 polysaccharide
lyases, 27 carbohydrate-binding modules, and 19 carbohydrate esterases identified to date(45).
Despite the significance of B. thetaiotaomicron in relation to both the human microflora and
glycomics, it remains poorly studied, with 24% of its genes not being significantly similar to other
characterized proteins in public databases, and 18% that are related to proteins or domains of
unknown function(60). The B. thetaiotaomicron enzymes which are the focus of this study are all
found in predictable positions within various PULs(61). Complete characterization, or at least
functional annotation of these protein products is critical to understanding biological processes
and the regulation thereof in the PULs of B. thetaiotaomicron and would contribute to knowledge
of the relationship between this organism and the human body(62). The PULs of interest in this
study can be seen below in Figure 1.
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Figure 1. Illustration of PULs of Interest. Red cells indicate genes coding for two-component histidine
kinase response regulator proteins, dark green cells for Starch Utilization System Type-C (SusC) proteins,
light green for Starch Utilization System Type-D (SusD) proteins, yellow for the proteins of interest, and
purple cells for the miscellaneous other members of the polysaccharide utilization loci. Notably, the targeted
factors always are preceded by the SusC/D in these PULs.

1.4.2 Protein/Domains of Unknown Function
As DNA sequencing tools and technologies have become progressively less expensive over
the past two decades the number of organisms with fully-sequenced, published genomes has
increased exponentially; from only 35 in the year 2000(63) to nearly 60,000 by 2015(64). As of
writing, the Joint Genome Institute (Walnut Creek, CA, USA) Genomes OnLine Database
(GOLD) has accepted a total of 361,646 genome sequences(65). The UniProt/TrEMBL database
contained slightly more than 230,000 protein sequences in 2000(66), with this increasing to 89
million protein sequence entries at the start of 2015(67). Functional annotation of these genomes
and proteins lags far behind, resulting in proteins and domains of unknown function outnumbering
characterized ones in nearly all categories, and with annotations often circulated through different
genomes without any experimental or gene context validation, misannotation is a common
problem(30). Domains of unknown function (DUFs) are a major contributing factor to the issue of
7

the deficit in functional attribution, structural characterization, and misannotation of genomes,
comprising approximately 22% of all families in the Pfam database(68). As the functional and
structural units of proteins are domains, and each domain tends to be distinct in these features,
experimental validation is required for each individual domain’s characterization(69). For these
reasons genomic, structural, and biochemical analysis of gene products is required to truly
determine the characteristics of almost any enzyme, particularly those containing DUFs(70),
including the proteins of interest selected for this study which is predicted to encode for three
DUFs. The problem of the prevalence of DUFs throughout genomes and gaps in our knowledge
with respect to proteins essential for the survival of a plethora of organisms has received significant
attention in the field of biochemistry as the number of sequenced genomes has ballooned in recent
years(71). As such, in addition to identifying CAZymes potentially useful in biotechnological
applications and adding context to the biological processes necessary for the survival of a vital
microbial symbiont, characterization of these enzymes will add to the collection of knowledge on
protein motifs and functional, as well as decrease the total number of domains of unknown function
in genome databases.
1.5

The Oral Microbiome, Periodontal Disease, and Porphyromonas gingivalis
Like the gut, the human oral cavity also contains a high concentration of bacteria, being

the second most diverse microbial community in the body with over 700 species of
microorganisms colonizing the various tissues(72). Like the gut microbiome, the oral microbiome
maintains a critical homeostasis, and dysbiosis in this community has a deleterious effect on the
health of both the symbiotic microorganisms of the oral microbiota and the host organism(73).
Periodontal diseases commonly arise as a result of oral microbiome dysbiosis(74) and are
pervasive across nearly all demographics; estimated to have affected at least 3.58 billion
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individuals globally in 2016(75), with severe periodontitis resulting in tooth loss occurring in 10 15% of the world population(76). The disease is not limited to just underdeveloped nations: over
50% of American adults are estimated to be affected by the disease(77). Economically,
periodontitis is responsible for approximately $54 billion globally in lost productivity and a
significant portion of the approximate $442 billion per annum cost of treating oral diseases(78).
Periodontal diseases are polymicrobial in nature and the pathogenic organisms responsible for
periodontal disease, such as those of the “Red Complex”, are also a component of the human
microbiome(79, 80). The Red Complex is a collection of three organisms: Treponema denticola,
Tannerella forsythia, and Porphyromonas gingivalis, each of which are critical keystone
organisms in the development of advanced periodontitis(81). The organism of interest in this study
is P. gingivalis, an organism with a species name that shares lineage with the condition called
gingivitis, for the tissue in which both are found. It is the organism most strongly associated of all
three in progression of the condition, being found in upwards of 85% of all subgingival plaque
sites(82, 83). The organism is a rod-shaped, non-motile, gram-negative, obligate anaerobe(84)
highly capable of adapting to the dynamic environment of the oral cavity and colonization of
plaque formations and host epithelial tissues(85). An important part of environmental adaptation
for P. gingivalis is modulation of the expression of genes in response to growth in a polymicrobial
biolfilm(81). Genes that are found to be upregulated in P. gingivalis during colonization of this
biofilm are of biological significance as they can be implicated in the survival and pathogenesis of
not just the organism itself, but also other organisms that exist within the biofilm as well(86).
These genes are often referred to as “putative virulence factors”(87).
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1.5.1 Putative Virulence Factors and Upregulation in Biofilm
Critical to the colonization and pathogenesis of P. gingivalis in the oral cavity is the
formation of a carbohydrate-rich biofilm(88). Establishment and colonization of this biofilm, as
well as invasion of host cells and tissues, requires a change in the expression of metabolic and
regulatory genes in the organism(82, 88), as well as the genes necessary for mitigation of the
immune response from the host organism(87, 89). Transcriptomic analysis was conducted on in
vitro co-cultures of the Red Complex organisms during the establishment of biofilms, in order to
identify genes that are upregulated relative to expression in planktonic cells(90). In the context of
microbial-host colonization, genes that were found to be upregulated in the biofilm can be defined
as biologically-significant factors, and characterizing the protein products may provide insight into
the pathogenic processes of P. gingivalis during this important colonization stage(91). Several of
these biologically-significant factors have been found to be putative CAZymes or CAZyme-related
proteins, or putatively exported factors(90). While it has long been known the organism is not
adept at utilizing carbohydrates as an energy source(92) (with some going so far as to classify it
as asacchrolytic(93, 94)), the genome of P. gingivalis encodes the genes necessary to conduct
glycolysis; as well as genes for the transport of glucose/galactose and degradation of complex
amino sugars(95). Other genes, often found to be upregulated during biofilm colonization, include
those related to glutamate metabolism, iron uptake, and cellular adhesion(84). The proteins
selected for study herein either have putative roles in, or are related to proteins with roles in, these
three biological functional. Elucidating the structure and function of these upregulated proteins
will assist in not only building a better model of P. gingivalis biofilm formation, but also reveal
potential therapeutic targets(96, 97).
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1.6

Research Objectives
The main goal of the B. thetaiotaomicron project is to structurally and functionally

characterize the conserved putative galactosidase enzymes in the selected polysaccharide
utilization loci, and to assign function to the domains of unknown function present in these
enzymes. The outcomes of protein characterization will then be submitted included in the CAZy
database in order to add to the collective knowledge of carbohydrate-degrading enzymes and
classify the as-yet unknown function of the domains within these proteins, as well as increase
understanding of the metabolism and glycobiology of B. thetaiotaomicron. It was hypothesized
that the protein would exist as two globular domains roughly split in half by sequence length, and
that C-terminal domain would contain the catalytic region of the protein.
Aim one for the BT project was to achieve the preliminary crystallization of the conserved
galactosidases BT2857, BT2966, and BT3158. This step was achieved through cloning,
expression, and analysis of the proteins for solubility and crystal growth in sitting-drop additive
screens covering a range of different buffered pH values, salts, and precipitating additives
(including sugars, alcohols, and various polyether compounds). After preliminary crystallization
was achieved using these sitting-drop screens, optimization of conditions were pursued using
hanging-drop 24-well expansion plates. Crystals deemed of an appropriate size and morphology
were cryoprotected, flash-frozen in liquid nitrogen, and sent to the Canadian Synchrotron Light
Source for X-ray diffraction analysis in order to determine the 3D structure of the enzymes.
Aim two for the BT project was to evaluate the functional hypotheses generated through
bioinformatics analysis of the proteins through kinetic assays utilizing substrate analogs and
through screening of possible carbohydrate substrates through thin-layer chromatography. Kinetic
assays were used to generate reaction rate constants for each of the enzymes. Once substrates that
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the enzymes can degrade had been identified, isolated samples of the product were then analyzed
via Nuclear Magnetic Resonance (NMR) and Mass Spectrometric (MS) analysis.
The third aim of the BT project was to determine the active domain of the enzymes through
truncation of the genes and to determine the active-site residues within these domains utilizing
site-directed mutagenesis and gene subcloning. Kinetic assays utilizing substrate-analogs were
then employed to assess catalytic activity in the truncated and mutated enzymes, and crystallization
trials were undertaken in an effort to attain enzyme structures complexed with substrate. The
activity (or the absence thereof) in mutant enzymes/truncations can be used to infer which domain
is most likely responsible for catalysis, as well as the active residues within those domains.
The goal of the P. gingivalis project was also to determine the structure and function of the
putative virulence factors PGN1176 and PGN1461, as well as the PGN1461-related protein
PGN1459. Classification of P. gingivalis proteins as putative virulence factors was determined
previously by transcriptomic analysis, which showed upregulation of these genes in P. gingivalis
during the co-colonization and localization of these organisms in the biofilm(98). PGN1459 was
determined to be another protein of interest due to its close location to the gene encoding PGN1461
in the P. gingivalis genome. Proteins successfully characterized can then be used to form a more
detailed model of pathogenicity for P. gingivalis as it relates to oral disease progression, and
structural/functional information can then be used to both determine if the proteins are possible
therapeutic targets and provide a starting for therapeutic development.
The first aim for this part of the project is to achieve the preliminary crystallization of the
proteins PGN1176, PGN1461, and PGN1459 through screening with a range of buffered pH
values, salts, and precipitating additives in 96-well sitting-drop plates. Optimization of these
preliminary conditions were pursued using both 24-well hanging drop and 96-well sitting-drop
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plates. Diffraction-quality crystals were then cryoprotected and sent for X-ray diffraction and
eventual structural solution, and iterative rounds of model building, refinement and validation.
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CHAPTER 2 - EXPERIMENTAL TECHNIQUES
2.1

Bioinformatics and Functional Hypothesis
The FASTA-format amino acid sequences of the selected proteins targets were taken from

the National Center for Biotechnology Information (NCBI) Protein database, and analyzed through
a series of bioinformatics resources in order to help predict the structure and function of the protein,
as well as determine certain parameters such as size and theoretical isoelectric points that will
assist in separating and identifying proteins throughout purification.
Gene codes for proteins of interest were searched for in the ELIXIR UniProt database in
order to view any putative functional annotation the target may have, and to provide easy access
the Kyoto Encyclopedia of Genes and Genomes (KEGG) entry for the protein. The KEGG is a
genome annotation database (https://www.genome.jp/kegg/) that uniquely allows for higher-level
functional speculation through its unique classification architecture and automated workflow.
Molecular functions of proteins are associated with ortholog groups so they can be associated
across organisms, while separately these ortholog groups are defined in the context of cellular
pathways and molecular relation networks(61). All members of the PUL from which the genes of
interest belong can be studied to fit the proteins into the broader genomic context of the loci, and
to try and ascertain the specific substrate being targeted(99). The amino acid sequences (found in
Appendix 2) will then be submitted to the STRING database (https://string-db.org/), which
generates a network of protein-protein interactions, physical and genomic, based on: experimental
co-expression analysis; detecting shared selective signals across the genome of the organism; textmining of scientific literature; and comparing interaction knowledge between organisms with gene
orthology(100). Combined with the user interface of the STRING tool, it allows for more genomewide detection of potential interactions, which will complement the information gathered from the
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KEGG analysis of the PULs present in BT. Proteins that are present and ordered into PULs, as
determined by KEGG, can be compared to the genome-wide results generated by STRING,
confirming the makeup of the KEGG PULs and potentially connecting the PULs of interest to
other pathways, providing more information that may help with determining the substrates and/or
roles of these polysaccharide-active gene clusters.
The amino acid sequences of target genes are then submitted to the ExPASy ProtParam
server to analyze the physical and chemical characteristics of the proteins. Output from this
analysis tool provides information such as: molecular weight, amino acid composition, theoretical
pI, 280 nm extinction coefficient, instability and aliphatic index scores based on the amino acid
sequences(101). The information on physiochemical properties can be applied in the identification,
solubilisation, purification, concentration, and storage of protein samples. Likely sites of
subcellular localization for the proteins were determined using the online PSORTb server, a
resource which analyzes the protein sequence for signal peptides, amino acid composition,
transmembrane helices, structural/sequence motifs, and homology to proteins of known
localization in the UniProt and Swiss-Prot databases(102). Information on putative subcellular
location will provide insight into not only where the proteins will be located after expression, but
also how these proteins may function and what their role is in their respective polysaccharide
utilization pathways. The ExPASy online tool TMpred were used to scan each protein of interest
for transmembrane domains. The tool searches for homology in submitted sequences against
experimentally determined transmembrane topologies in the Swiss-Prot database(103).
Identification, or lack thereof, of transmembrane domains will allow for an even more accurate
picture of protein location and function to be derived. The SignalP4.1 server was used to search
for the presence of signal peptide sequences in each protein as well(104), allowing for a more
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accurate determination of what the amino acid sequence will be in vivo following translation and
folding of the protein; information which can be used to obtain both a better preliminary structure
and fit for residues in the structures determined by X-ray diffraction. Conserved domains for each
protein will be investigated using the both the NCBI Basic Local Alignment Search Tool - protein
(BLASTp) and the EMBL-EBI InterPro online resources. Both tools seek to perform the same
task: accurately identify conserved domains in amino acid sequences, which may suggest a certain
function and/or structural feature of that protein. The main difference is the method of searching,
with BLAST utilizing multiple-sequence alignments of the query sequence with groups of
previously grouped conserved domains and calculating a position-specific score matrix
score(105), while InterPro utilizes an extra step where a Markov Matrix is generated and a node
map based on domain similarity is constructed, with the “flow” through nodes being used to most
similar domains(106). Domains determined to be similar to those of the target proteins may shed
light on the functional/mechanistic/structural properties of these proteins.
Putative 3D structural models of each protein will be generated with the online tools Phyre2
and RaptorX. These resources utilize initial multiple sequence alignments of the query protein with
template proteins in the PDB possessing experimentally determined structures followed by
Hidden-Markov Modelling to assess query-template fit, but differ in template selection parameters
and the subsequent iterative processes used in structural refinement. Phyre2 (Protein
Homology/analogY Recognition Engine V2.0) refines possible structures by first modelling a
crude backbone consisting of conserved regions, then adds loop and connective regions between
domains, and finally adding side chains in the lowest energy configuration(107). Query models
are constructed based on single templates, and each different query-template model is ranked based
on total coverage of the query sequence. RaptorX on the other hand integrates local and global
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structural context to better match distantly-related proteins or those with a low level of sequence
conservation(108).
Multiple sequence alignments of the galactose-binding like-domain protein sequences
from all homologous 4959/5126/5000 BT proteins, as well as previously characterized proteins
from other organisms, will be conducted using the online EMBL-EBI tool Clustal Omega, which
shows comparable accuracy to slower intensive alignments while being considerably faster and
more consistent than previous rapid methods(109). These alignments can be useful in identifying
conserved residues across the homologous BT proteins and orthologs found in other organisms,
from which common sugar-binding/catalysis motifs such and aspartate-x-aspartate/glutamate (DX-D/E)(110–112). These residues can then be visualized in either the homology- or
experimentally-modelled 3D structures of the target proteins to determine whether these residue
side chains are solvent-facing and capable of interacting with substrate.
2.2

Protein Expression and Solubility Screening
Initial attempts to isolate proteins from pelleted cell cultures were conducted through the

solubilisation of cells in a lysis solution containing a high concentration of sucrose (to initiate
osmotic shock), as well as sodium chloride and Tris:HCl buffer at pH 8.0. After homogenization
in the lysis buffer a detergent solution containing a low concentration of deoxycholic acid and
Triton X-100, along with sodium chloride and pH 8.0 Tris:HCl buffer, is added in order to stabilize
recombinant proteins. Lysis suspensions were centrifuged to pellet the insoluble fraction and yield
a supernatant that may contain the proteins of interest to be purified. If the protein of interest is
found in the pellet, rather than the supernatant, protein solubility conditions were screened for
alternative lysis conditions. Solution components that were varied include: buffering compound,
pH, salt type and concentration, and detergent conditions. Stock solutions containing high
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concentrations of these adjustable components were used to create a number of varied conditions
against which solubility can then be tested. To perform this assay, small amounts of cell pellet are
introduced into these custom conditions and sonicated for a short period at an ultrasonic frequency
to homogenize the pellets and disrupt cell walls/membranes. Solutions were then centrifuged and
analyzed for solubility of the recombinant protein.
If the protein was neither found in the pellet or the supernatant, the variation of expression
conditions were then tested. Conditions that can be altered include: makeup of media (ie. salts,
yeast extract amount, tryptone amount), media volume, induction temperature, usage of
autoinduction, and type of cellular expression system (ie. Tuner(DE3), BL21-CodonPlus).
2.3

Purification of Proteins
The techniques used to isolate and purify proteins during the course of these studies were:

immobilized-metal affinity chromatography (IMAC), anion-exchange chromatography, and
cation-exchange chromatography.
The form of IMAC employed was nickel-nitrilotriacetic acid (Ni-NTA), which employed
a resin designed to separate polyhistidine-tagged (6xHis) recombinant proteins from crude cell
lysate. Crosslinked agarose beads make up this resin, to which alkyl linkers are covalently bound.
Affixed to the end of these alkyl linkers are nitrilotriacetic acid molecules, which act as
quadridentate chelators for nickel(II) cations, effectively immobilizing the metal ions on the resin.
The two remaining coordination sites present on the immobilized nickel cation may then interact
with free electrons on the nitrogen atoms of the histidine side chains of C- or N-terminally 6xHistagged recombinant proteins. Once cell lysate has been applied through the resin, buffer was run
through the resin in order to wash residual crude extract proteins, and prevent the agarose beads
from damage as a result of drying out. Buffer containing incrementally higher concentrations of
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imidazole was then run through the resin in order to release the recombinant protein in a stepwise
manner. Imidazole is a cyclic aromatic molecule containing two non-adjacent nitrogen atoms
which competes with the 6xHis tags on recombinant proteins for nickel coordination sites. The
higher affinity of imidazole for these coordination sites causes the bound protein to elute off the
resin. Theoretically, Ni-NTA IMAC should be a “one-step” purification method, as nonrecombinant proteins lack a flexible 6xHis tag, however in practice significant amounts of
contaminant proteins may be present in fractionated samples due to protein-protein interactions,
non-specific protein-bead interactions, and/or presence of contaminants with charged surface
residues capable of coordinating to nickel(II). To remove these contaminants prior to fractionation,
the resin is washed with a comparatively large amount of buffer containing a low concentration of
imidazole.
Anion-exchange and cation-exchange chromatography are methods of purification that
isolate proteins based on a positively or negatively charged resin, respectively, interacting with
proteins that have a net complementary charge. In anion-exchange, the resin is positively charged
across an operational pH range of 2 to 12 and attracts negatively-charged proteins due to the
presence of a quaternary amine connected to crosslinked agarose beads via an alkyl linker.
Positively-charged buffers, such as Tris, are used in anion exchange to prevent interactions with
the resin and reduce the potential for inhibition of protein binding. The pH of the chosen buffer
must be greater than the isoelectric point (pI) of the protein of interest, typically by at least 0.5 – 1
pH units, while remaining ~0.6 pH units from the pKa of the buffer in order to both effectively
buffer the solution against pH change and negatively charge the protein. In cation-exchange, the
crosslinked agarose resin contains alkyl linkers with terminal sulphonyl groups that are negative
across a pH range of 2 to 14 and attracts positively-charged proteins. In the case of cation-
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exchange, negatively-charged buffers, such as HEPES, are preferred. The pH of the buffer must
be below that of the pI of the protein of interest, again by at least 0.5 – 1 pH units and within ~0.6
pH of buffer pKa. In both anion- and cation-exchange, proteins can be released from the resin
through the gradient addition of buffer containing a high concentration sodium chloride, which
contains both positive and negative ions that outcompete the proteins for the charged sites on the
resin, causing the protein of interest to be eluted out.
2.4

Separation and Purity Analysis of Proteins through SDS-PAGE
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a technique

that can be used to separate proteins based on molecular weight. SDS-PAGE gels generally consist
of a stacking gel, typically containing 4 – 6% (bis)acrylamide, layered over a resolving gel that
ranges between 8% and 12% (bis-)acrylamide for separation of mid-size proteins or 14 – 18% for
small proteins. The typical pH of the stacking and resolving gel sections are 6.8 and 8.8,
respectively. Crosslinking and polymerization of acrylamide and bis-acrylamide in solution is
catalyzed by the addition of tetramethylethylenediamine (TEMED) and ammonium persulfate
(APS). The stacking gel contains the wells in which protein samples are deposited and a short strip
of gel beneath these wells that serves to align the entire protein sample in as compact a band for
uniform introduction into the resolving gel. Before running protein samples on SDS-PAGE gels,
a loading buffer solution containing glycerol, sodium dodecyl sulfate (SDS), bromophenol blue,
and dithiothreitol (DTT) is added to the protein sample. Glycerol increases sample density easing
loading of sample into wells; SDS assists in denaturation of, and coats, proteins in the samples
with negative charge allowing for effective sample migration towards the anode; bromophenol
blue allows for easy visualization of samples during application, and DTT reduces disulfide bonds
in order to further denature proteins in samples. Protein/loading buffer mixtures are heated to
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accelerate denaturation of the sample. Total denaturation of the proteins in samples is vital to the
success of SDS-PAGE analysis, as any preserved secondary, tertiary, or quaternary structure will
affect the migration rate of the protein through the pores of the resolving gel and may result in
erroneous size or purity determinations being made. Gels are removed from glass casts after
running and submerged in Coomassie blue stain (containing Brilliant Blue R250 dye) before being
heated in order to visualize the protein(s) present. Stain is then decanted and gels are rinsed with
water, then heated in a destaining solution to remove excess stain that has been absorbed into the
gel.
2.5

Protein Concentration Determination through Spectral Analysis
Absorbance spectroscopy is an analytic technique that can be employed to determine the

concentration of protein present in a sample, based on the intrinsic fluorescent properties of the
particular protein being analyzed. The three amino acid residues that are considered when
quantifying the intrinsic fluorescent property of a protein are tryptophan (W), tyrosine (Y), and
phenylalanine (F), with maximal absorption wavelengths of 280, 274, and 257 nm, respectively.
Cysteine (C) residues may in some cases oxidatively dimerize and form disulfide-linked cystine
residues that somewhat contribute to the intrinsic fluorescence of a protein as well. The absorbance
of a protein sample is typically measured at 280 nm due to tryptophan having the highest quantum
yield (alternatively, having the lowest ratio of emitted electromagnetic radiation to absorbed
radiation) of the considered residues, and its absorbance spectra overlapping with that of tyrosine
and phenylalanine. The extinction coefficient for a given protein at 280 nm can be calculated using
the online bioinformatics tool ProtParam (by ExPASy), requiring only the amino acid sequence of
the protein. To practically apply this technique, a small amount of concentrated protein sample can
be diluted into a measured amount of buffer or water and absorbance at 280 nm (A280) can be
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determined. The Beer’s Law equation (A = ε ∙ c ∙ l) is then applied using the predicted extinction
coefficient and known sample pathlength to calculate the concentration of the diluted protein. The
original concentration of the undiluted protein sample can then be calculated, usually expressed in
units of micromolarity (μM). This micromolar measurement can also be converted to mg/mL using
the calculated molecular weight of the protein.
2.6

Kinetic Activity Analysis of Enzymes through Spectroscopic Measurement of

Nitrophenol Release from Substrate Analogs
Optimal operating pH/temperature, kinetic rates, and Michaelis-Menten constants for
certain proteins may be determined through the liberation of a nitrophenol indicator molecule from
a substrate analog. This type of assay can be especially valuable for assessing the activity, and to
some degree stereochemistry, of glycosidase enzymes where the mechanism involves the cleavage
of O-glycosidic bonds. Examples of prototypical retaining and inverting hydrolase reactions can
be seen in Figures 2 and 3.

https://www.cazypedia.org/index.php/Glycoside_hydrolases

Figure 2. Example of the typical mechanism utilized by retaining glycoside hydrolases.
Substrate shown in illustration is of “ɑ” anomeric carbon conformation. The nucleophilic
residue directly attacks the anomeric carbon of the substrate, while the acid/base residue
provides a proton allowing for bond cleavage which is then followed by activation of a water
molecule that allows for cleavage of the bond between the substrate and nucleophilic residue.
22

https://www.cazypedia.org/index.php/Glycoside_hydrolases

Figure 3. Example of the typical mechanism utilized by inverting glycoside hydrolases.
Substrate shown in illustration is of “ɑ” anomeric carbon conformation. The Lewis base
residue directly activates a water molecule allowing for hydrolysis, while the leaving group is
protonated by a Brønsted-Lowry acid residue.
In glycoside hydrolase assays utilizing nitrophenol-based colourimetry, a saccharide (ie. galactose,
xylose, maltose, etc.) covalently bound via an ether linkage to a nitrophenyl moiety. As with
natural carbohydrates, the nitrophenyl linkage may assume either “α” or “β” conformation,
allowing for the selective testing of either α- and β-glycosidase activity. The most common type
of nitrophenol moiety, and the one utilized throughout this study, is para-nitrophenol (pNP),
though ortho- and meta- forms of the analog may also be used. These substrate-mimicking
compounds are initially colourless in solution, but upon cleavage of the nitrophenyl group from
the sugar substituent the solution will turn a yellow colour due to the resonance structure of the
nitrophenolate ion at basic pH values, which can be easily measured at a wavelength of 405 nm.
Illustration of pNP-based substrate analogs and the pNP liberated from the analogs via enzymatic
cleavage can be seen in Figure 4.
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https://www.megazyme.com/

Figure 4. para-nitrophenyl-based substrate analogs used in the kinetic analysis of
putative glycoside hydrolase enzymes. Left to right: 4-nitrophenyl-α-D-galactopyranoside,
4-nitrophenyl-β-D-galactopyranoside, para-nitrophenol catalysis product. The paranitrophenol product is generated by enzyme-mediated hydrolysis of the ether bond in
substrate analog and allows for colourimetric determination of enzyme activity.
The structure of pNP analogs allows for the compounds to be dissolved in water for pH optima
determination, or buffer, for usage in Michaelis-Menten kinetic assay. Due to the pH of the given
system affecting the amount of free nitrophenol that is present in the ionic form, a range of
standards with a known concentration of pNP and solution pathlength will be needed in order to
determine the extinction coefficient for the range of pHs utilized in a pH optima assay. Extinction
coefficients can be calculated by rearranging Beer’s Law to ε = (A / [c ∙ l]). This standard assay,
along with pH optima and Michaelis-Menten assays, can be conducted in a microplate to easily
allow for multiple readings with a variety of solution conditions. Absorbance readings from
pH/Michaelis-Menten assays can be used to calculate the amount of pNP present in the solution,
and from this calculate the rate of degradation of the substrate analog, which can be used to
determine the kinetic parameters for each enzyme.
2.7

Site-Directed Mutagenesis of Potential Active-Site Residues
Site-directed mutagenesis can be used to identify potential catalytically-active residues in

the enzymes of interest through the substitution of these residues to ones that contain inert sidechains. The method utilized in this study to produce such mutants was the Single-Oligonucleotide
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Mutagenesis and Cloning Approach (SOMA). This process takes advantage of the ability of highprocessivity DNA polymerases to replicate entire plasmids and certain stains of E. coli to recircularize and complement single-stranded plasmid DNA. To conduct mutagenesis using SOMA,
a single oligonucleotide (referred to subsequently as the “primer”) is synthesized to complement
an 18 - 25 nucleotide section of the plasmid that contains the codon for the amino acid designated
to be mutated, with a codon on the primer containing the minimal number of “mismatched”
nucleotides required to result in the section coding for an amino acid with an inert side-chain. In
order to generate a mutant plasmid, a high-fidelity high-processivity polymerase, such as the
Pyrococcus furiosus-derived Pfu, is utilized. A standard PCR protocol is followed, with the time
in the elongation step suitably extended to allow for the polymerase to copy the full length of the
plasmid, only terminating once it has reached the opposite end of the primer. Following generation
of these single-stranded “plasmids”, the restriction enzyme DpnI is introduced into the reaction
mixture. DpnI recognizes the nucleotide sequence GATC/CTAG, where the adenine on both
strands is methylated, and cuts DNA at these points, between the adenine and thymine nucleotides.
Bacteria extensively methylate plasmid DNA to protect it from degradation, while DNA
polymerase is capable of generating only unmethylated DNA. As such, DpnI will breakdown the
parent strands of plasmid DNA while leaving the single-stranded mutant DNA untouched.
Reactions can then be run on an agarose gel to assess if mutant plasmid has been generated.
Mixtures that contain plasmid may be purified and transformed into competent DH5ɑ E. coli cells,
where the linear strands will be recircularized and complementary strands formed with innate
cellular machinery. Cells can be plated onto LB-agar media supplemented with a selective
antibiotic and colonies selected for, which will be grown prior to plasmid DNA extraction.
Extracted DNA can then be validated for the presence of the desired mutation.
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2.8

Screening of Potential Carbohydrate Substrates through Thin-Layer

Chromatography
Targets that showed activity against pNP analogs can be tested against potential
carbohydrate substrates using thin-layer chromatography. In this assay, di-/oligo-saccharides
containing (a) monosaccharide component(s) that are the same as or structurally similar to that of
the carbohydrate substituent in the pNP analog from the kinetic assays would be tested for
degradation by the target enzymes. Carbohydrates were first dissolved in the buffer conditions that
were found to be suitable for protein stability. Buffer/carbohydrate mix were then divided into
equal volumes into two tubes for incubation, with one being left without protein and the other
having a set amount of protein introduced into it. The carbohydrate mixtures may then be incubated
under agitation for an extended period of time in order to allow for the potential degradation to
proceed. Following this incubation 95% ethanol was added to all tubes and incubated for one hour
in order to arrest the reaction and denature the protein present in solution. Tubes can then be spun
at high rpm to pellet denatured protein, leaving a mixture of buffer, ethanol, and carbohydrate. The
remaining solution can be transferred to a new centrifuge tube and concentrated via rotary
evaporation. Following the concentration of the mixtures to an appropriate volume, the solutions
were then spotted onto a silica TLC plate and run using a polar solvent. After drying, carbohydrates
were visualized by staining through the application to and heating of p-anisidine on the plate,
which under heat will condense with any carbonyl/amine groups present on the saccharides,
making it an excellent general-purpose stain(113).
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2.9

Product Characterization Using Nuclear-Magnetic Resonance and Mass

Spectrometry
Due to the high variability of carbohydrate substrates/products and the diversity of ways in
which CAZymes may degrade these carbohydrates, multiple methods of analysis such as mass
spectrometry (MS) and nuclear-magnetic resonance (NMR) spectroscopy is often required to
determine the structure of even simple mono/di-saccharides. Digestion of carbohydrates by
proteins can be conducted in the same or similar manner to that of those conducted for TLC.
Purification of carbohydrates from protein mixture may require extra care as analyte conditions
are more stringent for these methods of analysis, requiring not only the removal of protein, but
often also all salts, buffering agents, and certain solvents. Reaction products may also require
separation prior to analysis.
Nuclear-magnetic resonance spectroscopy is a useful analytical technique for the
elucidation of carbohydrate structure, providing information on the number, identity, modifying
groups, and anomeric configuration of monosaccharide residues, as well as linkages
sequences(114). The process takes advantage the intrinsic nuclear-magnetic moment of atoms
containing an odd number of protons/neutrons, most commonly single-proton hydrogen (1H) and
the six-proton/seven-neutron isotope carbon-13 (13C). A strong magnetic field is applied to the
samples to align the nuclear-magnetic spin of the atoms, after which a weak oscillating magnetic
field is applied in order to disturb the magnetic fields in the aligned atoms. As the magnetic spin
of the atoms relaxes back to equilibrium, a voltage is produced within a detection coil. The voltages
generated are then used to generate a spectrum based on the frequency and intensity of these
voltages as compared to standard.
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Mass spectrometry is a technique that is commonly combined with NMR to determine the
structure of carbohydrates. MS can provide information on the molecular mass, monosaccharide
substituents and sequence, linkage types, modifying groups, and stereochemistry of
carbohydrates(115). In this technique a purified sample is ionized, a process which results in the
molecules being transferred into the gas phase, and the ions are transported to a mass analyzer
under the power of a magnetic or electric field. A mass analyzer separates these ionized sample
molecules based on their respective mass-to-charge ratios (m/z), which can measured in several
different ways including: sector instruments that alter the linear trajectory of the sample using a
static magnetic/electric field; time-of-flight analyzers which accelerate particles based on their
potential and measures the time it takes for the particles to reach the detector; quadrupole analyzers
that destabilize particles outside of a particular m/z range the device has been tuned to; and ion
traps that capture and sequentially eject particles as the electric field within the trap is altered.
2.10

Crystal Screening and Diffraction Optimization
X-ray crystallography has been considered the gold-standard for protein structure

determination for over 50 years(116), and thus will be critical to the determination of the structure
of the target proteins. The first step in the determination of an X-ray crystal structure is the
preliminary crystallization of the target proteins. To achieve preliminary crystallization, proteins
that have been purified to near homogeneity and had all inclusions/aggregates removed from
concentrated samples must be tested for stability, nucleation, and crystal growth across a wide
variety of buffer, pH, salt, precipitant, and additive concentrations. For the purposes of preliminary
crystallization commercially-available pre-made sparse-matrix screening solutions containing
these variety of components are utilized. Protein samples were mixed with screening solution at
certain ratios and situated above a reservoir of the same screening solution (known as the sitting-
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drop vapour-diffusion method) and each well containing protein/precipitant droplets and the
corresponding solution reservoir was individually sealed. For optimization of conditions found to
produce crystals in sitting-drop conditions, the hanging-drop method is frequently utilized, where
the protein/precipitant mixtures are suspended above solution reservoir on an inverted coverslip,
sealed with vacuum grease, which isolates the droplet/reservoir system. In this method buffer,
precipitating agent, salt, additive, reservoir volume, and protein concentration can be finely
tailored in an attempt to increase crystal size and quality. In both methods vapour diffusion is the
driving force behind crystallization. As the suspended protein droplet contains a higher percentage
of water compared to the reservoir solution, over time this solution component will diffuse from
the droplet into the reservoir solution, shrinking the droplet and gradually increasing the
concentration of all other components in the system, including protein. As the protein and
precipitating compounds are gradually concentrated in this dynamic liquid environment the
chances of nucleation increase as eventually crystallization of protein and precipitant becomes the
most entropically favourable state for the components(117). Addition of substrates or substratemimicking compounds may also be added to protein/precipitant mixtures before or after
crystallization in an attempt to populate active sites, which can may help in the determination of
catalytic function/mechanism.
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CHAPTER 3 - MATERIALS AND METHODOLOGY
3.1

Materials
The cloned gene targets, BT2109, BT2918, BT3158 in pET15b vectors; BT2857 in the

pET15TV-LIC vector, and BT2966 in pET28a were sent to us in collaboration with Dr. Alicia
Lammerts Van Bueren (Faculty of Mathematics and Natural Sciences, Microbial Physiology) from
the Gron Institute of Biomolecular Sciences & Biotechnology (Groningen, Netherlands). fd codon
optimized synthetic genes of BT2857C, BT2857N, PGN1176, PGN1461, and PGN1459 in
pET21b(+) plasmids were ordered from BioBasic (Markham, ON, Canada). Calcium-competent
NEB 5-α (cat# C2987I) and BL21 (DE3) (cat# C2527I) E. coli cells were purchased from New
England Biolabs Inc. (Ipswich, MA, USA). Competent BL21-CodonPlus (DE3)-RIPL E. coli cells
(cat# 230280) from Agilent (Santa Clara, CA, USA) were borrowed from Dr. Weadge’s lab.
Competent Novagen Tuner™ (DE3)pLysS E. coli cells (cat# 70624-3) were purchased from
MilliporeSigma (Burlington, MA, USA). Plasmid miniprep kits GeneJET and QIAprep® were
purchased from Thermo Fisher Scientific (Waltham, MA, USA) and QIAGEN (Hilden, Germany),
respectively. Restriction enzymes XhoI, NdeI, BamHI, DpnI; Cutsmart buffer, Phusion® HighFidelity PCR Kit, Calf-Intestine Alkaline Phosphatase, T4 DNA ligase, and T4 DNA ligase buffer
were also purchased from New England Biolabs Inc. The premixed DNA polymerase solution “2X
PCR Bestaq™ MasterMix” was ordered through Applied Biological Materials (Richmond, BC,
Canada). JumpStart™ Taq ReadyMix™ was ordered through Sigma-Aldrich (St. Louis, MO,
USA). QIAquick PCR purification and QIAquick Gel Extraction kits were purchased through
QIAGEN. Primers were ordered through Integrated DNA Technologies (Coralville, IA, USA).
Tryptone, yeast extract, agar A, monobasic sodium phosphate dihydrate (NaH2PO4 ∙
2H2O), sodium acetate trihydrate (CH3COO ∙ 3H2O), PIPES (free acid form), hydrochloric acid
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(HCl), bicine, calcium chloride dihydrate (CaCl2 ∙ 2H2O), ammonium sulfate ((NH4)2SO4),
nickel(II) chloride hexahydrate (NiCl2 ∙ 6H2O), potassium bromide (KBr), iron(III) chloride
hexahydrate (FeCl3 ∙ 6H2O), zinc(II) sulfate heptahydrate (ZnSO4 ∙ 7H2O), copper(II) chloride
monohydrate (CuCl2 ∙ H2O), sodium sulfate anhydrous (Na2SO4), deoxycholic acid sodium salt,
ethidium bromide, D-lactose monohydrate, isopropanol, were purchased through BioBasic Inc.
(Markham, ON, Canada).
Agarose, tris (base), bis-tris, bis-tris propane, CAPS, CHES, HEPES, anhydrous dibasic
sodium phosphate (Na2HPO4), glacial acetic acid, succinic acid, glycine, trisodium citrate
dihydrate (Na3C6H5O7 ∙ 2H2O), magnesium chloride hexahydrate (MgCl2 ∙ 6H2O), sodium
chloride (NaCl), magnesium sulfate heptahydrate (MgSO4 ∙ 7H2O), imidazole, anhydrous
monobasic potassium phosphate (KH2PO4), manganese chloride tetrahydrate (MnCl2 ∙ 4H2O),
Triton

X-100,

sucrose, isopropyl

β-D-1-thiogalactopyranoside,

ampicillin,

kanamycin,

chloramphenicol, guanidine hydrochloride, 1-butanol, EDTA disodium dihydrate, 40% 19:1
acrylamide:bis-acrylamide solution, TEMED, glycerol, and ethylene glycol were purchased from
Bioshop Canada Inc. (Burlington, ON, Canada).
Ammonium acetate, potassium tartrate, sodium potassium tartrate tetrahydrate, cobalt(II)
chloride anhydrous (CoCl2), glucose, TLC-tested carbohydrates, pNP-carbohydrate analogs, panisidine, D2O, polyethylene glycol 1500, 3000, 4000, 6000, and polyethylene glycol monomethyl
ether 2000 were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA). Sodium hydroxide
and anhydrous citric acid were purchased through Anachemia (Mississauga, ON, Canada).
Ammonium persulfate ((NH4)2S2O8) and Coomassie Brilliant Blue R-250 was purchased from
Fisher Scientific Inc. (Hampton, NH, USA). 100% methanol and 95% ethanol were obtained from
CFS Chemicals (Montréal, QC, Canada). Potassium chloride (KCl) and lithium sulfate
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monohydrate were purchased from Alfa Aesar (Ward Hill, MA, USA). Lithium nitrate and
aluminum-backed F60 silica TLC plates were purchased from EMD Millipore Inc. (Burlington,
MA, USA). 96-well flat-bottom Nunc™ MicroWell microplates used in functional assays were
purchased through ThermoFisher Scientic (Waltham, MA, USA). 96-well sitting-drop crystal trays
were purchased from Art Robbins Instruments LLC (Sunnyvale, CA, USA). 24-well cell culture
plates used in crystallization trials, 1.5mL and 0.6mL microcentrifuge tubes, and pipette tips were
purchased from Sarstedt Ag & Co. (Nümbrecht, Germany). High-vacuum grease was purchased
from Dow-Corning Inc. (Midland, MI, USA). Silica coverslips, Crystal Screen, and Crystal Screen
2 were purchased from Hampton Research Corp. (Aliso Viejo, CA, USA). MCSG crystal screens
were purchased from Anatrace Inc. (Maumee, OH, Canada).
3.2

Methodology and Experimental Design

3.2.1 Introduction into and Extraction of Recombinant Plasmids in E. coli Cells
BT2109, BT2857, BT2918, BT2966, BT3158 plasmids and BT2857N, BT2857C,
PGN1176, PGN1459, PGN1461 custom genes were transformed into calcium-competent NEB 5α, BL21, BL21-CodonPlus, and Tuner E. coli cells via heat shock methodology. 50μL aliquots of
competent cells in 1.5mL microcentrifuge tubes were thawed on ice for 5 minutes, after which 1 5μL of vector DNA solution was added to cells and incubated on ice for 30 minutes. Following
incubation cells were subjected to heat shock at 42°C for 60 seconds and placed back on ice for 5
minutes. 200μL of high-NaCl LB broth medium was then added to tubes and transformations were
incubated for one hour at 37°C and 240rpm before being spread on ampicillin-, kanamycin-, or
ampicillin/kanamycin+chloramphenicol-containing LB-agar plates as appropriate. Plates were
incubated overnight at 37°C to allow for growth, and single colonies were picked from plates and
grown overnight in either 5mL or 10mL cultures of LB broth containing antibiotics at 37°C and
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240rpm. Standard antibiotic working concentrations used for LB broth cultures was 100μg/mL for
ampicillin, 50μg/mL for kanamycin, and 25μg/mL for chloramphenicol.
Glycerol stocks of transformed cells were generated by pipetting 650μL of overnight
cultures into 1.5mL microcentrifuge tubes after which 650μL of sterile 50% glycerol was then
added and mixed via pipetting. Tubes were then submerged upright in liquid nitrogen until
completely frozen, then stored in -80°C ultra-low freezer (Thermo Scientific™ Forma 88000
Series).
Plasmid vectors were harvested from NEB 5-α overnight cultures using either GeneJet or
QIAprep plasmid miniprep kits. 1mL sample of overnight culture was pelleted down at 17,900xg
for 5 minutes in tabletop centrifuge, supernatant was decanted, and pellet was then resuspended in
250μL of a resuspension solution. 250μL of a lysis solution containing RNase was then added to
the resuspension and the reaction was allowed to proceed for up to 5 minutes. 350μL of
neutralization solution was then added to the solution and tubes were mixed by inverting, before
being centrifuged for 10 minutes at 17,900xg to remove precipitated cellular components. 800μL
of supernatant was then pipetted into a tube containing a silica column, which was then spun for
one minute to absorb DNA into the silica. Flow through was decanted from the lower collection
tube and 750μL of an ethanol-containing wash buffer was pipetted onto the silica column before
being spun for one minute, decanted, and spun again for one minute. 50μL of an elution buffer of
10mM Tris:HCl at pH8.5 was then pipetted directly onto the silica and incubated for one minute
after which the column was placed in a sterilized 1.5mL microcentrifuge tube and centrifuged for
one minute to elute DNA. The concentration of the isolated DNA was determined via nanodrop
analysis and tubes were then stored at -20°C for subsequent use.
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3.2.2 Protein Expression and Initial Isolation
Overnight cultures of BL21 (DE3), BL21-CodonPlus (DE3)-RIPL, or Tuner™
(DE3)pLysS E. coli cells containing desired vector were prepared by introducing a small amount
of ultra-frozen glycerol cell stock to 10mL of LB media containing antibiotics at standard working
concentrations. Cultures were incubated overnight at 37°C and 240rpm before being inoculated
into 1L cultures of high-NaCl LB broth containing appropriate antibiotic(s) at standard
concentrations (100μg/mL ampicillin; 50μg/mL kanamycin; 25μg/mL chloramphenicol). 1L
cultures were incubated under the same conditions as overnight cultures until an OD600 of 0.6 –
0.8 was reached, at which point isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added to the
cultures to a final concentration of 1mM and incubation conditions were changed to 16°C and
160rpm to facilitate overexpression of the desired protein. Other expression media used included
2-YT and Terrific broth (both containing tryptone, yeast extract, and sodium chloride) at a volume
of 500mL per flask, and autoinduction-LB at 1L/flask. For autoinduction-LB, standard LB was
dissolved in 925mL of water and autoclaved, after which 50mL of 20x P salt solution, 20mL of
50x 5052 solution, 1mL of 1M MgSO4, 1mL 1000x trace-metal mix, and 3.5mL 11M NaOH to
achieve a media pH of ~7.5. Autoinduction cultures were left at 37°C, 240rpm, for 8 hours after
inoculation before being moved to 16°C 160rpm conditions for overnight expression. After
overnight expression, cells were harvested via centrifugation at 5000rpm for 15 minutes at 4°C. If
not immediately lysed, cell pellets were stored at -20°C in 50mL falcon tubes.
Overnight cultures for cells expressed in SelenoMethionine minimal media were grown at
a volume of 100mL per litre of culture. Cultures were pelleted by centrifugation at 5000rpm, 4°C,
before being resuspended in a volume of M9 minimal media equal to that of the culture volume
and pelleted again. Pellets were again resuspended in M9 minimal media, at a volume of

34

25mL/100mL of culture. 25mL of resuspended cells were added to each 1L culture contained in
baffled 2L flasks, and cultures were grown and induced under the same conditions as described
above for LB and 2YT cultures.
For chemical lysis cell pellets were initially dissolved in a beaker on ice with a volume of
730mM sucrose solution containing 300mM NaCl; buffered with Tris:HCl, HEPES:NaOH, or
dibasic sodium phosphate (Na2HPO4), at pH7.0 - 8.0. Once the pellet had completely homogenized
with sucrose solution, lysozyme was added to concentration of 1mg/mL and the solution was left
under agitation for 10 minutes before the addition of 2 volumes of detergent solution (1%(w/v)
deoxycholate, 2%(w/v) Triton X-100, 300mM NaCl, buffered identically to sucrose solution used).
1M MgCl2 and 2mg/mL DNase I solutions were then added and the solution was left for up to 30
minutes, or until the lysis solution was no longer highly viscous. The soluble and insoluble
fractions were separated by centrifugation at 25,000xg for 45 minutes at 4°C, supernatant was kept
as crude extract for isolation of protein target.
Prior to immobilized metal affinity chromatography (IMAC), Ni-NTA resin was
suspended in crude protein extract in 50mL falcon tubes and incubated under inversion for 30 - 90
minutes at 4°C in a Fisher Scientific 346 mixer. After incubation the resin/extract mixture was
decanted into a Bio-Rad Econo-Column® and allowed to drain back into falcon tubes as isolate
“flow-through”. Wash and elution buffers used during IMAC contained the same buffering/salt
conditions as lysis buffer. Wash buffer containing buffer, salt, and 5mM imidazole was poured
over resin with care given to not disturb the settled resin. A flow adaptor, connected to a Bio-Rad
Econo™ Gradient Pump, was placed in the column ~5mm above the resin bed and 50mL of wash
buffer was run through the column. After washing, proteins were eluted off the resin through
gradient application of elution buffer containing increasing concentrations of imidazole (25, 50,
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75, 100, 125, 150, 175, 200, 225, 250mM) and collected in 10mL fractions. Column and resin was
then cleaned by adding one column volume 500mM imidazole, one column volume water, one
volume 0.5M NaOH, one volume water, one volume 10%(v/v) acetic acid, one volume water,
before being stored in 20%(v/v) ethanol.
3.2.3 SDS-PAGE Analysis
Insoluble pellet, IMAC flow-through, column wash, and eluted fractions were kept for
assessment of expression, solubility, and purity after initial isolation. 20μL of each sample was
mixed with 5μL of 5x SDS-PAGE sample buffer in 0.6mL microcentrifuge tubes, and then heated
at 85°C for 5 minutes. Samples were loaded into 12%(w/v) SDS-PAGE gel along with Bio-Rad
Precision Plus Protein™ Dual Color Standards ladder. Gels were run at 180V for 50 minutes. Gel
recipe can be seen in Table 1.

Table 1. Solution compositions and volumes used in the making of SDS-PAGE gels. Both
recipes makes a total of 10mL of gel solution. These volumes are suitable for the casting of 2
separating gels and 10 separating gels.
Solution
40% 19:1 acrylamide/bisacrylamide
milliQ H2O
1.5M Tris:HCl pH8.8
0.5M Tris:HCl pH6.8
10% w/v SDS
TEMED
10% w/v APS

Separating Gel (12%)
3.1mL

Stacking Gel (4%)
1.008mL

4.235mL
2.5mL
100μL
15μL
50μL

6.332mL
2.5mL
100μL
10μL
50μL

After running, gels were placed in Tupperware containers with Coomassie stain and heated
in a 700W microwave for one minute. Stain was emptied from container and gels were rinsed and
submerged in clean water, then heated in microwave for 3 minutes to de-stain and visualize protein
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bands. De-stained gels were imaged using Bio-Rad VersaDoc™ MP 4000 Molecular Imager and
adjusted using Quantity One® 1-dimensional analysis software.
3.2.4 Dialysis of Protein
SDS-PAGE analysis of IMAC samples was used to determine which fractions contained
an acceptable amount of contamination bands as compared to the amount of purified protein target.
Fractions with a high degree of purity were dialyzed to decrease the concentrations imidazole and
salt, and in some cases change buffering conditions, in preparation for further purification via fast
protein liquid chromatography. Selected fractions were pooled in Fisherbrand™ 50mm
Regenerated Cellulose dialysis tubing with a molecular weight cut-off (MWCO) of 6,000 8,000Da. Tubing was clipped at both ends with 50mm polyamide SnakeSkin™ or Sigma closures.
Dialysis bags containing pooled fractions were then submerged in 2L of milliQ water agitated with
a magnetic stir bar and left at 4°C for one hour. After one hour, dialysis bags were transferred to
2L beakers of desired buffer (ie. Tris:HCl, HEPES:NaOH, Na2HPO4) and left overnight at 4°C
under stir bar agitation. If aggregates/inclusion bodies were seen in protein solution after overnight
dialysis, the solution was poured into 50mL falcon tubes and spun at 4300xg for 20 minutes at 4°C
in Beckman Coulter Allegra X-14R swinging-bucket centrifuge to pellet the insoluble protein.
Soluble protein solution, free of aggregates, was stored at 4°C until further purification could be
conducted.
3.2.5 Purification Through Anion and Cation Exchange Chromatography
Protein samples that had undergone dialysis after IMAC purification were run through
anion- and or cation-exchange fast protein liquid chromatography (FPLC) to further purify the
protein prior to crystallization and functional assay. Purification via these techniques was
performed using the GE Healthcare ÄKTA pure protein purification system, controlled by
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protocols in the UNICORN 6.4 Workstation software. Before running ion-exchange protocols,
lines were purged with buffers being used in the protocol, with protein sample line purge bypassing
the ion exchange column, 1M NaCl-containing buffer being run over the column until the UV
signal at 280nm reached 0 milli-Absorbance Units (mAU) to clear any protein left in the column,
and non-salt buffer being run over the column until conductivity flatlined to prime column for
sample application. Flow rate for these steps was 5mL/min, and column pressure was ensured to
be below 0.5 megapascals (MPa). For anion exchange with a GE 5mL HiTrap Q FF column the
positively charged buffer Tris:HCl at pH8.0 was used, while negatively charged HEPES:NaOH at
pH7.5 was used for cation exchange with a GE 5mL SP Sepharose FF column. In the standard
protocols utilized for both anion and cation exchange all buffer and sample lines were primed
before the application of sample. After priming, sample was run over the column twice to ensure
maximum interaction between resin and protein. The column was then washed with 15mL of the
respective wash buffer before elution. Elution buffer, comprised of 1M NaCl in the same buffer
condition used in the wash, was then applied to the columns in gradient from 1 - 100%, causing
the gradual release of proteins from the column as chloride ions (in anion exchange) or sodium
ions (in cation exchange) outcompete the proteins for resin interaction. Elution was collected in
3mL fractions, and fractions that corresponded to the greatest peak in the UV280 signal were run
on SDS-PAGE gels to verify the presence and purity of the target protein.
3.2.6 Ultrafiltration and Determination of Protein Concentration
FPLC-purified protein was concentrated using Amicron® Ultracel-15 regenerated cellulose
centrifugal filters purchased through Millipore. Centrifugal filters with MWCO of 10 or 30kDa
were used depending on the size of the protein being concentrated, with 30kDa being used for all
full-length BT proteins and PGN1461, 10kDa being used for BT2857C, BT2857N, PGN1176 and
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PGN1459. Before concentration filters were filled with milliQ water, mixed briefly, and left to
soak for 10 minutes in order to hydrate the cellulose membrane. Water was emptied from filter
unit, protein sample was placed in the upper compartment of the filter, and filters were spun in
Allegra X-14R swinging bucket centrifuge at 4000xg, 4°C, for 15 minutes. Flow-through was
emptied from the bottom compartment of the filter and the upper compartment was refilled with
unconcentrated protein sample, and the centrifugation process was repeated until protein had
reached an acceptable level of concentration, typically between 10mg/mL and 40mg/mL. If the
protein sample at the bottom of the upper filter compartment began to appear yellow or brown, a
P1000 pipette would be used to gently agitate and homogenize the sample. After ultrafiltration,
samples were pipetted into 1.5mL microcentrifuge tubes and spun for 30 minutes in Beckman
Coulter Microfuge® 20R at 20000xg, 4°C, to pellet any inclusion bodies that may have formed
during concentration. Concentrated protein sample was moved into fresh 1.5mL microcentrifuge
tubes after spinning.
Concentration of protein samples was determined by measuring the absorbance of
tryptophan residues at UV280 using Thermo Scientific™ Genesys 10S UV-Vis Spectrophotometer.
Spectrophotometer was blanked with 1000μL of milliQ water in Sarstedt UV transparent LCG
8.5mm cuvettes, after which 5μL of protein sample was added to the water and homogenized in
solution by pipetting up and down with a P1000 pipette. Absorbance spectra from 260 - 300nm
was collected and the reading at 280nm was taken to calculate the protein concentration in the
cuvette using Beer’s Law. The equation is rearranged from “A = ε ∙ c ∙ l” to “c = A / (ε ∙ l)”, where
A = UV280 value, ε = proteins extinction coefficient as determined by EXPasy Protparam, and l =
1cm. Extinction coefficients for each protein can be found in Appendix 3. The dilution factor is
then calculated and applied to the sample, where “sample concentration = cuvette concentration ∙
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(1005μL / 5μL)”. Protein concentration in units of mg/mL can also be calculated using the equation
“concentration(mg/mL) = concentration(mol/L) ∙ MW(g/mol) ∙ (1L/1000mL) ∙ (1000mg/1g)”.
These calculations were done automatically using Microsoft Excel software.
3.2.7 Crystal Screening and Expansion Plating
Initial screening for stable, meta-stable, and crystal-forming conditions was conducted in
Art Robbins Instruments (ARI) 96-well sitting-drop crystal trays (102-0001-03 type) using the
ARI Crystal Gryphon automated plating system and pre-made first-pass crystallization condition
screens from Anatrace Inc., Hampton Research Corp., and Molecular Dimensions Ltd. Protein
sample to reservoir solution ratios used in sitting-drop screening were 1:1, 2:3, or 2:1. After setup,
sitting-drop trays were labelled and sealed with Duck® HD Clear tape before being stored at 18°C
in Molecular Dimensions 100L Benchtop Incubator. Trays were observed under a Zeiss SteREO
Discovery.V8 microscope after 3 days, then at the end of every multiple of 7 days after incubation.
Successful hits for crystallization conditions were recorded on scoring sheets for crystal growth
optimization.
The primary technique used for optimization was hanging-drop vapour-diffusion in 24well Sarstedt TC cell culture plates. Each expansion plate focused on one or more conditions that
yielded successful crystallization in 96-well plates, with aspects such buffer, pH, stabilizing
additive, salt/protein concentration, and amount of precipitant being altered slightly to test for ideal
crystal growth. Reservoir solutions were prepared in each well and vacuum grease was applied
around the rim of each well. Six siliconized glass coverslips were laid on the benchtop and droplets
of reservoir solution from wells A1 - A6 were applied to/around the centre of the slip using a P10
pipette. Protein was then added to A1 coverslip droplet(s) and the coverslip was inverted and
placed overtop of well A1, with light pressure applied to seal the well and prevent the ingress of
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air. Process was repeated with wells A2 - A6. The procedure outlined for row A was then repeated
for rows B, C, and D, individually. Plates were labelled, dated and placed in 18°C incubator or
4°C cold room. Diagrams describing conditions for coverslips with multiple droplets were drawn
on expansion plate formulation sheet. Volumes of both reservoir solution and protein sample were
increased for hanging-drop expansion plate droplets, typically by a factor of 10 (ie. 5/6μL hanging
droplet vs. 0.5/0.6μL sitting-drop).
Another technique utilized for optimization was formulation of custom 96-well sitting-drop
plates. Reservoir solutions were prepared in empty sterile 96-well deep well blocks from BioBasic
(BR581-96N). Plating was again performed using the ARI Gryphon automated system with 1020001-03 sitting-drop trays, with final drop volumes being doubled to 1-1.2μL. Trays were sealed,
stored, and observed in same manner as initial-screen plates.
Crystals generated by both hanging-drop and sitting-drop vapour diffusion were
cryoprotected in a variety of solutions (usually liquid reservoir conditions supplemented with 30%
glycerol or ethylene glycol) and frozen in liquid nitrogen prior to shipping. Crystals were analyzed
at the Canadian Light Source Synchrotron (CLS/CCRS) in Saskatoon, SK, Canada. Datasets for
native crystals were collected on both CMCF-ID and CMCF-BM beamlines, while anomalous
diffraction data were collected on the CMCF-BM beamline. Examples of preliminary statistics for
the diffraction of targets can be seen in Appendix 7.
3.2.8 Enzyme Activity Assays
Kinetic assaying of the B. thetaiotaomicron enzymes was performed using paranitrophenyl substrate analogs for simple colourimetric detection and quantification of reaction
rates. All para-nitrophenyl assays were conducted in Nunc™ Microwell 96-well flat-bottom
microplates, measured using a BioTek® (Winooski, VT, USA) Cytation5 cell imaging multi-mode
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reader, both graciously provided by Dr. Weadge’s lab. pH profiles for each enzyme were
determined by incubating 2μL of 625μM enzyme with 1mM para-nitrophenyl-β or αgalactopyranoside (pNP-Gal) in a pH range of 100mM McIlvaine buffers at a final volume of
250μL. Reactions were conducted in triplicate at room temperature (~25°C), for 60 minutes with
reads taken at 52 second intervals. To produce Michaelis-Menten curves, 2μL of 625μM enzyme
was incubated with pNP-Gal substrate analog at increasing concentrations. Reactions were again
run in triplicate, 25°C, at 250μL, for 60 minutes with 52 second read intervals. Typical plate setup
for Michaelis-Menten kinetic assays can be seen in Table 2.
Table 2. Typical Microplate Setup for pNP Michaelis-Menten Kinetic Assays. Volume of
10mM pNP-carbohydrate solution in 100mM buffer recorded in top third of each cell; volume
of 100mM buffer recorded in middle of each cell; volume of protein solution listed in bottom
third of each cell. Row A served as control for auto-hydrolysis of pNP substrates.
1

2

3

4

5

6

7

8

9

10

11

12

A

1.25μL
248.75μL

2.5μL
247.5μL

3.75μL
246.25μL

5μL
245μL

6.25μL
243.75μL

12.5μL
237.5μL

25μL
225μL

50μL
200μL

75μL
175μL

100μL
150μL

125μL
125μL

150μL
100μL

B

1.25μL
246.75μL
2μL
1.25μL
246.75μL
2μL
1.25μL
246.75μL
2μL

2.5μL
245.5μL
2μL
2.5μL
245.5μL
2μL
2.5μL
245.5μL
2μL

3.75μL
244.25μL
2μL
3.75μL
244.25μL
2μL
3.75μL
244.25μL
2μL

5μL
243μL
2μL
5μL
243μL
2μL
5μL
243μL
2μL

6.25μL
241.75μL
2μL
6.25μL
241.75μL
2μL
6.25μL
241.75μL
2μL

12.5μL
235.5μL
2μL
12.5μL
235.5μL
2μL
12.5μL
235.5μL
2μL

25μL
223μL
2μL
25μL
223μL
2μL
25μL
223μL
2μL

50μL
198μL
2μL
50μL
198μL
2μL
50μL
198μL
2μL

75μL
173μL
2μL
75μL
173μL
2μL
75μL
173μL
2μL

100μL
148μL
2μL
100μL
148μL
2μL
100μL
148μL
2μL

125μL
123μL
2μL
125μL
123μL
2μL
125μL
123μL
2μL

150μL
98μL
2μL
150μL
98μL
2μL
150μL
98μL
2μL

C
D

The rate for each reaction (in Abs/min) was calculated for each pH/substrate concentration,
and converted to M/min using Beer’s Law. Michaelis-Menten values of Vmax and KM were
determined by the equation of the curve for each construct. The kcat value was calculated using the
formula kcat = Vmax/Et, where “Et” is the defined the total enzyme concentration. Enzymes that
showed activity against pNP-β-Gal were expressed in E. coli Tuner (DE3)pLyss cells to confirm
galactosidase activity, a cell line that does not contain the lacZ gene, which codes for an
42

endogenous β-galactosidase that may cause above-background hydrolysis of the pNP-β-Gal
substrate.
Enzymes determined to have potential activity against carbohydrates were screened against
variety of available (poly)saccharides. 5mg of each polysaccharide was dissolved in 495μL of
phosphate buffer at ideal pH as determined by pH optima assay, in 1.5mL microcentrifuge tubes.
5μL of enzyme at 25mg/mL was added to the solution and left overnight at 240rpm, 37°C.
Reactions were quenched with 500μL of 95% reagent ethanol and left for 60 minutes at room
temperature. Microcentrifuge tubes were spun at 14,800rpm in tabletop centrifuge for 30 minutes
to pellet protein in reaction mixture, and supernatant was transferred into sterile 1.5mL
microcentrifuge tubes via pipetting. Supernatants were vacuum concentrated at 40°C to ~50100μL using the tabletop CentriVap concentrator from the Labconco Corporation (Kansas City,
MO, USA). Samples were run on Silica gel 60 aluminum TLC plates (MilliporeSigma) using 1butanol:acetic acid:water solvent at a 2:1:1 volume ratio until the solvent front was 1cm from the
top of the plate. Plates were left to dry completely before 1% (w/v) p-anisidine stain (dissolved in
10% (v/v) methanol, 90% (v/v) 1-butanol) was applied, plates were then baked at 130°C for 10
minutes to visualize carbohydrates. TLC separation was also utilized to separate products for
NMR, with a larger amount of product applied to plates (5 - 20mg). 1cm sections of plate were
then removed from the edges and stained to check if angular migration on the plate had occurred.
After verification of migration uniformity, a line was drawn across the remaining unstained plate
separating the areas where digested products were assumed to be. Silica gel was then scraped from
each plate section and placed in a beaker. Each sectional scrape was dissolved in 35mL of methanol
and agitated with a magnetic stir bar at 200rpm, room temperature, for 30 minutes. Samples were
vacuum concentrated until dry and redissolved in D2O in preparation for NMR analysis.
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3.2.9 Site-Directed Mutagenesis and Subcloning
Site-directed mutagenesis (SDM) of BT2857C and BT2857N was undertaken in an attempt
to identify active-site residues through subsequent pNP kinetic analyses. Primers were created
based on guidelines in the Agilent QuickChange Site-Directed Mutagenesis Kit. Primer pellets
were resuspended in QIAGEN “EB buffer” (10mM Tris:HCl pH8.0) to a final concentration of
1mM. Working primer stocks at 100μM were prepared via dilution with EB buffer. Mutants were
generated using the single-oligonucleotide mutagenesis and cloning approach (SOMA) with
Phusion® High-Fidelity DNA polymerase. Conditions such as DMSO/MgCl2 concentration, buffer
composition, and annealing temperatures were altered if standard procedure did not achieve
mutagenesis. Primer sequences can be found in Appendix 4. Protocols can be seen in Table 3 and
Table 4.
Table 3. Reagent volumes typically used in Phusion DNA Polymerase SOMA protocol
for SDM of BT2857 constructs. Reactions were conducted in Bio Basic flat-cap 0.2mL thinwall PCR tubes.
Reagent
5X Phusion buffer (HF or GC)
10mM dNTP mix
100ng/μL Primer
Template DNA
100% DMSO (optional)
50mM MgCl2 (optional)
2,000U/μL Phusion polymerase
Nuclease-free H2O

Volume
10μL
1 - 3μL
5μL
μL for 100 - 250ng
0.5 - 4.5μL
0.5 - 4.5μL
0.5μL
to 50μL total volume

Table 4. Typical thermal cycler temperature profile for SOMA mutagenesis of BT2857
constructs. Reactions were conducted in a Bio-Rad Laboratories Inc. T100™ Thermal
Cycler utilizing a heated lid to prevent evaporation of reagents during procedure.
Step
Initial Denaturation
Denaturation
Annealing
Elongation
Final Elongation
Hold

Temperature (°C)
98
98
55 - 61
72
72
4

Time (s)
60
30
30
270
360
∞
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# of Cycles
1
35
1
1

Following PCR, 2μL of 20000U/mL DpnI restriction enzyme was added directly to the
reaction mixture, and tubes were incubated at 37°C, 240rpm, for one hour in order to degrade any
methylated parental DNA, and then inactivated at 80°C for 20 minutes. Following DpnI digestion,
PCR reactions were run on a 0.7% (w/v) agarose gel alongside an NEB Quick-Load® 1kb DNA
Ladder in order to visualize banding and determine if the generation of mutagenic plasmids was
successful. Digested reactions that showed a single band at the expected size were cleaned using
the QIAquick PCR purification kit and transformed into competent NEB 5-α E. coli. cells.
Colonies were picked and grown in 5mL overnight for plasmid isolation. Concentration of isolated
plasmids was analyzed, and positive sequencing confirmed at the Robarts Research Institute
(University of Western Ontario, London, ON, Canada).
The subcloning of the DUF4959 domains from BT2857N (pET21b(+)) and BT3158
(pET15b) into the pET21b plasmid first involved PCR amplification of the genes. PCR was
conducted using both JumpStart™ Taq ReadyMix™ and 2X PCR Bestaq™ MasterMix, and the
standard protocol can be seen in Table 5 and Table 6.
Table 5. Reagent volumes used in PCR amplifications of DUF4959 in BT2857/3158.
Reactions were conducted in Bio Basic flat-cap 0.2mL thin-wall PCR tubes.
Reagent
100ng/μL Forward Primer
100ng/μL Reverse Primer
Template DNA
Jumpstart ReadyMix Taq
Nuclease-free H2O

Volume
5μL
5μL
μL for 100 - 250ng
25μL
to 50μL
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Table 6. Typical thermal cycler temperature profile for DUF4959 PCR amplifications.
Reactions were conducted in a Bio-Rad Laboratories Inc. T100™ Thermal Cycler utilizing a
heated lid to prevent evaporation of reagents during procedure.
Step
Initial Denaturation
Denaturation
Annealing
Elongation
Final Elongation
Hold

Temperature (°C)
94
94
61
72
72
4

Time (s)
60
30
45
90
300
∞

# of Cycles
1
35
1
1

Successful amplification was identified by agarose gel electrophoresis, where reaction mixtures
were run on 0.7% (w/v) gels along with NEB Quick-Load® 100bp DNA Ladder. Reactions that
showed singular banding at the expected length were purified and analyzed for concentration.
Purified mixtures were then digested using the restriction enzymes NdeI and XhoI. Standard
protocol can be seen in Table 7. Plasmid vectors were also digested using this procedure, with
alkaline phosphatase buffer and alkaline phosphatase enzyme added to prevent re-ligation.
Table 7. Reagent volumes for DUF4959/pET21b(+) digestion reactions. Reactions were
conducted in Bio Basic flat-cap 0.2mL thin-wall PCR tubes heated at 37°C for 1 hour in a
shaking incubator at 200rpm. Digestions were arrested via heating tubes to 80°C for 20
minutes in a Bio-Rad T100™ thermocycler.
Reagent
XhoI
NdeI
10X CutSmart buffer
5,000U/μL calf-intestine alkaline phosphatase
plasmid/fragment DNA
nuclease-free H2O

Volume
1μL
1μL
5μL
2.5μL
to 1μg
to 50μL

Digested products were cleaned using QIAquick PCR purification kit and analyzed for
concentration. Purified digestion products were ligated with T4 DNA ligase into plasmid vector at
either a 1:3 or 1:5 plasmid:fragment concentration. Standard protocol can be seen in Table 8.
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Table 8. Reagent volumes for DUF4959/pET21b(+) ligation reactions. Reactions were
conducted in Bio Basic flat-cap 0.2mL thin-wall PCR tubes cooled to 16°C in a shaking
incubator set to 200rpm for 18 hours. Reactions were inactivated by heating tubes to 65°C for
10 minutes.
Reagent
Volume
T4 DNA ligase
1μL
10X T4 DNA ligase buffer
2μL
Vector DNA
to
Insert DNA
to
nuclease-free H2O
to 20μL
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CHAPTER 4 - RESULTS
4.1.1 Structural Prediction and Functional Hypothesis for B. thetaiotaomicron Proteins
The amino acid sequences for BT2109, BT2857, BT2918, BT2966, and BT3158, were
analyzed via a series bioinformatics tools in order to form a hypothesis on the structure and
function of the target proteins, as well as to elucidate how these proteins may fit into the broader
function of the polysaccharide utilization loci to which they belong. Outputs from InterPro and
BLASTp both confirmed the conservation of three domains of interest/unknown function across
the five target proteins. The BLASTp illustrations of DUF positions in the proteins of interest can
be seen in Figure 5. The N-terminal DUF 4959 is classified under the Pfam family PF16323, and
may contain a fibronectin type-III structure. DUF 5126 was found to be a member of Pfam family

Figure 5. Illustration of BLASTp Outputs for Target DUFs. While BLASTp did not
register BT2966 as having a DUF5000 domain despite containing the F5/8-type C
superfamily, InterPro analysis did confirm the domain as being present.
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PF17166 and had no structural motif associated with it. The C-terminal DUF 5000, a member of
PF16391, likely contains a short helical F5/F8-type C (discoidin) fold; a fold associated with
amphipathic membrane binding (118). The DUF5000 sequences were also found to overlap
significantly with galactose-binding-like domain superfamily IPR008979. The IPR008979
superfamily does not have a prototypical structure assigned to it, though a number of 3D
XRD/NMR structures from both prokaryotic (ie. PDB IDs: 1CX1, 1EUT, 1DP0) and eukaryotic
(ie. PDB IDs: 1BHG, 1GOF, 1I5P) CAZymes have been generated. IPR008979 domains present
in these example proteins vary in length (140 – 370 amino acids) and have low sequence similarity
but contain similar β-sandwich tertiary structure which forms a jelly-roll fold.
Output from the TMpred online resource showed short sections of a potential transmembrane
region covering the first 21 to 24 residues in each target protein, however outputs from the
SignalP4.1 server showed signal peptide regions overlapping with these potential transmembrane
regions, suggesting the proteins do not possess a transmembrane region following subcellular
localization. Results from the PSORTb online resource were inconsistent between the target
proteins, with only BT3158 having a result of relatively high confidence, with a score of 8.96/10.00
for cytoplasmic localization, with scores of 0.51 for the cytoplasmic membrane, 0.26 for the
periplasm, 0.01 for the outer membrane, and 0.26 for extracellular localization. Three target
proteins: BT2109, BT2918, and BT2966 showed scores of 2.00/10.00 for all five potential
localizations. BT2857 showed scores of 0.00, 4.90, 2.50, 0.10, and 2.50 for cytoplasmic,
cytoplasmic membrane, periplasm, outer membrane, and extracellular localization, respectively,
suggesting the protein may have multiple sites of subcellular localization.
The overall best homology models generated by intensive Phyre2 modelling also showed a
diversity in possible structure for each of the five target proteins, despite the conservation in DUFs.
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A number of these structures lack a modelled fibronectin type-III domain predicted to be at the Nterminal of the protein. Homology models were superimposed using the MatchMaker function in
UCSF Chimera with alignment conducted using the Needleman-Wunsch algorithm and
BLOSUM62 matrix with a gap-extension penalty of 1 with distant residue pairs iteratively pruned
to a level of 2.0Å or lower. These models can be seen in Figure 6., notably with the C-terminal

Figure 6. Phyre2 Intensive Homology Models of B. thetaiotaomicron Target Proteins. A),
B), C), D), and E) representing Phyre2 models generated from the amino acid sequences of
BT2109, BT2857, BT2918, BT2966, and BT3158, respectively. F) depicts all homology
models overlaid based on structural similarity as determined by the UCSF Chimera
MatchMaker function, with colours of each target model being identical to those of the A – E.
models.
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DUF5000 domain being the center of the alignment for all five of the models. The MatchAlign
function was used to analyze the similarity of the models after superimposition, with a residueresidue cutoff of 10.0Å used and alignment iterated until convergence across the whole alignment.
This analysis generated values of 1.937Å for the RMSD, 47.9 for Sequence Distance-Measure,
and 0.004 for Overall Quality (out of a possible 1.000). Notably, of the 5 targets that were modelled
only the output for BT2109 had a region that overlapped with DUF4959 and showed significant
resemblance to a fibronectin type-III domain. Protein target sequences were submitted to the
RaptorX homology modelling server to validate the structures generated by Phyre2. Models
produced by RaptorX can be seen in Figure 7.

Figure 7. RaptorX Homology Models of B. thetaiotaomicron Target Proteins. A), B), C),
D), and E) representing BT2109, BT2857, BT2918, BT2966, and BT3158, respectively.
Notable differences from Phyre2 includes: DUF4959 being modelled similarly to a fibronectin
type-III domain in BT2109, BT2857, and BT3158; more extensive secondary-structure
character across the sequences; distension of sequence segments that do not contain
secondary structure character.
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4.1.2 Model Prediction and Functional Hypothesis for P. gingivalis Proteins
The amino acid sequences of PGN1176, PGN1459, and PGN1461 were analyzed via the
same bioinformatics tools as those used on the B. thetaiotaomicron proteins, also for the purpose
of forming a hypothesis regarding the structure and function of the proteins, as well as hypothesize
how they may contribute to the pathogen virulence for the purpose of building a better model of
periodontal disease. Outputs from InterPro and BLASTp were used to either verify the putative
functional annotation in the UniProt entry for the protein or form preliminary hypotheses for
entries with no proposed function. The BLASTp results can be seen in Figure 8.

Figure 8. Illustrated BLASTp Domain Results for Porphyromonas gingivalis Target
Proteins. Detailed results regarding all (non-)specific hits and some superfamily membership
omitted for clarity. Based on sequence similarity Pgn1176 is suggested to belong to the
PRK05808 (3-hydroxybutyryl-CoA dehydrogenase) superfamily, Pgn1459 is suggested to
belong to the YicC uncharacterized conserved protein superfamily, and Pgn1461 is suggested
to have two Gate superfamily domains found in nucleoside transporter FeoB GTPases.
In the case of PGN1176, the PRK05808 superfamily identified by BLASTp agreed with the
UniProt proposed function of being a 3-hydroxybutyryl CoA-dehydrogenase, while a Specific Hit
in BLASTp suggested the protein contains a FadB domain. The InterPro output matched with these
results, identifying the IPR022694 family to cover the full length of the protein. An NAD(P)+
binding domain (a member of the adenosylmethionine-dependent methyltransferase superfamily)
was found to be located between amino acids 2 and 181 by both BLASTp and InterPro. InterPro
and BLASTp outputs for PGN1459 both identified the protein to contain a YicC-like domain
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stretching across the full length of the sequence (InterPro family IPR005229, pfam PF03755), a
domain that has been associated with maintaining proper morphology of bacterium in which it is
expressed in stationary-phase growth, and required for growth under high temperatures (37°C 45°C). InterPro output for PGN1459 also showed the presence of Domain of Unknown Function
1732 between amino acids of 208 and 291 (pfam: PF08340), a domain that may bind nucleic acids.
PGN1461 was found to be annotated as a putative fused type A/B spore-maturation protein.
BLASTp output for PGN1461 agreed with UniProt annotation, with the spore maturation domain
SpmA covering amino acid residues 3 - 204, and SpmB covering residues 245 - 410. A suspected
nucleoside gate domain is present within both the SpmA and SpmB domains according to the
BLASTp analysis, at residues 52 - 155 and 278 - 379, respectively. InterPro outputs further
validated the BLASTp and UniProt results, however the server only identified a single gate domain
at residues 52 - 154. Gate domains in PGN1461 were also noted to have homology to those found
in FeoB iron transport membrane proteins responsible for Fe2+ uptake(119). The SignalP4.1 server
identified no signal peptide in the amino acid sequences for PGN1176, PGN1459, or PGN1461.
TMPred predicted two possible transmembrane helices in PGN1176, one in outsideinside
orientation at residues 1 – 19, and one in insideoutside orientation at residues 226 – 246, results
which contradicted PSORTb results, which predicted cytosolic localization with a 99.7% degree
of confidence (cytosolic membrane and periplasm localization were predicted with 0.1% and 0.1%
confidence, respectively). For PGN1459 TMPred predicted no transmembrane domains, and
subcellular localization as predicted by PSORTb showed the same results as PGN1176. TMpred
predicted PGN1461 to contain a total of 10 transmembrane helices in alternating
insideoutside/outsideinside orientation throughout the length of the protein, agreeing with
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results from PSORTb analysis showing a 100% chance of the protein being localized to the
cytosolic membrane. PGN1461 TMPred results can be seen in Figure 9.

Figure 9. TMPred Output for Porphyromonas gingivalis Target Protein PGN1461.
Values above 0 indicate regions of probable transmembrane character in the protein of
interest. Legend can be seen in the top right corner, with io and oi indicating
insideoutside and outsideinside orientation predictions, with “inside” being cytosol and
“outside” being periplasm. The preferred model determined the first transmembrane helix to
be insideoutside, with subsequent helices alternating orientation.

Amino acid sequences for each target protein were submitted to the Phyre2 and RaptorX
servers for homology modelling to assess possible conformations of the proteins and find
previously characterized proteins that may be used as templates for molecular replacement.
PGN1176 was modelled with a high degree of confidence in Phyre2, with 100% of residues being
modelled at above 90% confidence, with the best template being another probable 354

hydroxybutyryl-CoA dehydrogenase (PDB ID: 3MOG) from strain K12 E. coli, with which it
shares 41% amino acid sequence identity. The model generated by RaptorX was based on the
template

6ACQ,

another

3-hydroxybutyryl-CoA

dehydrogenase,

from

Clostridium

acetobutylicum, with 100% of residues modelled having a Global Distance Test (GDT) score of

Figure 10. Phyre2 (left) and RaptorX (right) Homology Models of PGN1176. Figures
were generated and models compared using UCSF Chimera. MatchAlign analysis of
superimposed structures with parameters of 5.0Å cutoff resulted in an overall RMSD of
0.892Å; sequence length of 281; SDM of 8.912; and Quality score of 0.919, showing that the
generated structures possess a high degree of similarity.
84, greatly exceeding the threshold of acceptability of 50. The homology models for PGN1176
can be seen Figure 10.
PGN1459 was modelled with a low degree of confidence in both Phyre2 and RaptorX; with Phyre2
modelling no residues at >90% confidence and the top template having only 62.8% confidence
despite having 36% amino acid sequence identity, while the RaptorX model had a GDT
significantly below the acceptable threshold of 50, at only 29. The RaptorX model had an
unnormalized GDT of 84; indicating sections of the structure may be accurate to the structure. The
Phyre2 and RaptorX servers both modelled potential structures for PGN1459 on template proteins
dominated by α-helical secondary structures and often involved in cellular signalling (6QAJ and
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2D1L in Phyre2; 3I9W in RaptorX). Homology models generated by these resources can be seen
in Figure 11.

Figure 11. Phyre2 (top) and RaptorX (bottom) homology models of PGN1459. Phyre2
model based primarily on NMR solution structure of human calcium-binding non-muscle
myosin IIA (PDB ID: 2LNK) and X-ray diffracted solution of human nuclear protein
KAP1/TRIM28 (PDB ID: 6QAJ). RaptorX model based on X-ray diffraction structure of
strain 12 E. coli histidine kinase sensor domain (PDB ID: 3I9W).

PGN1461 was modelled with moderate levels of confidence using Phyre2, mainly across the
sections of the primary sequence predicted to be nucleoside gate domains. Primary templates for
Phyre2 homology model were two nucleoside permease proteins, 5L2B from strain 12 E. coli and
3TIJ from Vibrio cholera, with 87.8%/83.2% homology confidence and 21%/18% sequence
identity to PGN1461, respectively. Quality indicators for the RaptorX also predicted moderate
confidence in the overall homology model, with an unnormalized GDT of 85 and GDT of 20,
indicating sections of the model are likely accurate, though not the global structure. Top ranked
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templates from both servers used to build PGN1461 homology models consisted of transmembrane
transporters (including concentrative nucleoside transporters and aminobenzoyl-glutamate (AbgT)
family transporters), the same class of proteins that PGN1461 was predicted to be a member of
according to previous bioinformatics results. Also of note was that all top templates exist as trimers
in crystal form according to the associated literature, suggesting the proteins may form a trimeric
channel-type transporter with a variety of potential substrates in an intracellular environment(120–
123). Model predictions for single polypeptide strands of PGN1461 can be seen in Figure 12.

Figure 12. Phyre2 (left) and RaptorX (right) homology models of PGN1461. Sequences
were determined to be highly dissimilar according to a MatchAlign analysis using a 5.0Å
cutoff in UCSF Chimera, with results of 2.621Å for RMSD, 410 for sequence length, 113.386
for SDM, and 0.032 for Overall Quality.
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4.2.1 Expression and Purification of B. thetaiotaomicron Proteins
The first step in the characterization of the B. thetaiotaomicron enzymes was optimizing
the expression and purification of the proteins. Expression of BT2109, BT2857, and BT3158 was
conducted in 1L high-salt (10mg/mL) LB cultures, supplemented with 100mg/L ampicillin and
induced with IPTG at a final concentration of 1mM, using BL21 (DE3) E. coli cells. BT2918 and
BT2966 were expressed in Rosetta™(DE3) E. coli cells in 1L high-salt LB cultures, supplemented
with chloramphenicol and ampicillin (BT2918) or kanamycin (BT2966), and induced with 1mM
IPTG. Cell lysis using solutions buffered with 50mM Tris:HCl pH8.0 and containing 300mM NaCl
in addition to standard sucrose and detergent concentrations (730mM and 1% deoxycholate/2&
Triton X-100, respectively) was found to be appropriate for all BT proteins. After homogenized
cell lysate was centrifuged supernatant was removed and subjected to IMAC isolation. The
standard IMAC resin incubation period used was 60 minutes, but could range from immediate
flow through to 2 hours depending on what length of time was found to be ideal for the individual
construct being isolated: 0 minutes for BT2109; 60 minutes for BT2857, BT2918, and BT3158; 2
hours for BT2966. SDS-PAGE analysis of collected IMAC fractions can be seen in Figure 13 –
14.
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A)

B)

C)

D)

E)

F)

Figure 13. SDS-PAGE Gels for the IMAC Isolation of Full-Length B. thetaiotaomicron
Proteins. 12% (w/v) SDS-PAGE gels were loaded with prepared elution samples of
increasing imidazole concentration. Gels A), B), C), D), and E) correspond to isolations of
BT2109, BT2857, BT2918, BT2966, and BT3158, respectively. Legend for lanes in each gel
is depicted in F). Bio-Rad Protein-Plus™ Dual Color Standards ladder was used in lane 1. All
constructs expected to be found at ~45kDa.
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A)

B)

C)

D)

E)
Figure 14. SDS-PAGE Gels for the IMAC Isolation of Truncated and Truncated
Mutant BT2857 Proteins. 12% (w/v) SDS-PAGE gels were loaded with prepared elution
samples of increasing imidazole concentration. Gels A), B), C), D), and E) correspond to
isolations of BT2857N, BT2857C, BT2857C D256A mutant, BT2857C D239A-D242A
mutant, and BT2857C H300A-D304A mutant, respectively. Order of elution/imidazole
concentration is identical to that of the full-length B. thetaiotaomicron isolations. Bio-Rad
Protein-Plus™ Dual Color Standards ladder was used in lane 1. BT2857N expected to be
found at 22kDa and BT2857C constructs at 19kDa.
Following IMAC isolation fractions 3 - 8 were pooled for each full-length construct except
BT2918, where fractions 5 - 12 were pooled, and dialyzed into salt-free Tris:HCl buffer prior to
anion-exchange chromatography. Notably, BT2918 consistently formed a higher amount of visible
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inclusion bodies than other constructs over the course of dialysis. Any protein samples that had
visible inclusion bodies following dialysis were centrifuged at 4,300xg for 20 minutes to remove
inclusions. IMAC fractions of BT2857C and its associated mutants were determined to be at
apparent homogeneity after only this initial isolation, and did not undergo anion-exchange FPLC.
Examples of anion-exchange FPLC chromatograms and associated SDS-PAGE analysis of protein
purification can be seen in Figures 15 – 19.

Figure 15. Chromatogram from BT2109
Anion-Exchange Run (Top) and SDS-PAGE
Analysis of Anion-Exchange Purification
(Left). Protein content depicted by blue line,
salt content depicted by brown line. 12% (w/v)
SDS-PAGE loaded with flow-through (lane 2)
and every-other elution fraction from 14 to 38
was loaded in lanes 3 - 15. Bio-Rad ProteinPlus™ Dual Color Standards ladder was used
in lane 1.
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Figure 16. Chromatogram from BT2857 Anion-Exchange
Run (Top) and SDS-PAGE Analysis of Anion-Exchange
Purification (Left). 12% (w/v) SDS-PAGE loaded with flowthrough (lane 2) and every-other elution fraction from 14 to 38
was loaded in lanes 3 - 15. Bio-Rad Protein-Plus™ Dual Color
Standards ladder was used in lane 1.

Figure 17. Chromatogram from BT2857N
Anion-Exchange Run (Top) and SDSPAGE Analysis of Anion-Exchange
Purification (Left). 12% (w/v) SDS-PAGE
loaded with flow-through (lane 2) and everyother elution fraction from 14 to 38 was
loaded in lanes 3 - 15. Bio-Rad Protein-Plus™
Dual Color Standards ladder was used in lane
1.
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Figure 18. Chromatogram from BT2966
Anion-Exchange Run (Top) and SDSPAGE Analysis of Anion-Exchange
Purification (Left). 12% (w/v) SDS-PAGE
loaded with flow-through (lane 2) and everyother elution fraction from 14 to 38 was
loaded in lanes 3 - 15. Bio-Rad ProteinPlus™ Dual Color Standards ladder was used
in lane 1.

Figure 19. Chromatogram from
BT3158 Anion-Exchange Run (Top)
and SDS-PAGE Analysis of AnionExchange Purification (Left). 12%
(w/v) SDS-PAGE loaded with flowthrough (lane 2) and every-other
elution fraction from 14 to 38 was
loaded in lanes 3 - 15. Bio-Rad
Protein-Plus™ Dual Color Standards
ladder was used in lane 1.
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4.2.2 Expression and Purification of P. gingivalis Proteins
As with B. thetaiotaomicron proteins, expression of P. gingivalis targets was the first step
in characterization. PGN1176 was expressed in high-salt 1L LB cultures, PGN1461 in 500mL
2YT cultures, and PGN1459 in 1L autoinduction-LB cultures with BL21 (DE3) E. coli cells. All
cultures were supplemented with 100mg/L ampicillin and induced with IPTG at 1mM final
concentration. 50mM Tris:HCl pH8.0 buffered lysis solutions containing 300mM NaCl were
determined to be sufficient for solubilisation of PGN1176, while 100mM HEPES:NaOH pH7.5
with 750mM NaCl and 300mM NaCl was found to optimally solubilize PGN1459 and PGN1461,
respectively. Cell lysate was initially subjected to IMAC isolation with resin incubations varied
from 30 to 60 minutes depending on the construct being purified. SDS-PAGE gels can be seen in
Figure 20.
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A)

B)

C)
Figure 20. SDS-PAGE Gels for the IMAC Isolation of P. gingivalis Proteins. 12% (w/v)
SDS-PAGE gels were loaded with prepared elution samples of increasing imidazole
concentration. Gels A), B), C) correspond to isolations of PGN1176, PGN1459 and
PGN1461, respectively. Bio-Rad Protein-Plus™ Dual Color Standards ladder was used in
lane 1. Banding for PGN1176 expected at 30kDa, PGN1459 at 34kDa, and PGN1461 at
44kDa.
For constructs PGN1176 and PGN1459 fractions 6 – 12 (125mM – 250mM imidazole) and 8 – 12
(175mM – 250mM imidazole), respectively, were determined to be of high enough purity and
yield to proceed to functional/crystallization trials without requiring further purification via FPLC.
PGN1461 was dialyzed into salt-free 100mM HEPES:NaOH pH7.5 prior to FPLC purification.
Cation-exchange chromatography was initially pursued as a purification method for PGN1461 as
the theoretical pI of the protein was found to be 8.97 in ProtParam analysis; however it was found
that the protein failed to bind to the column and anion-exchange was used in subsequent
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purifications. Chromatograms and associated SDS-PAGE gels for these purifications can be seen
in Figures 21 - 22.

Figure 21. Chromatogram of PGN1461 Cation-Exchange FPLC Purification Attempt.
Run was stopped and column was cleaned after it became apparent the protein had not bound
to the cation exchange column. Protein content via UV 280nm absorbance depicted by blue
line, salt content depicted by brown line. No PGN1461 adhered to the column.

Figure 22. Chromatogram from PGN1461
Anion-Exchange Run (Top) and SDS-PAGE
Analysis of Anion-Exchange Purification
(Left). 12% (w/v) SDS-PAGE loaded with
flow-through (lane 2) and every-other elution
fraction from 14 to 38 was loaded in lanes 3 15. Bio-Rad Protein-Plus™ Dual Color
Standards ladder was used in lane 1.
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4.3

Kinetic and Mechanistic Characterization of B. thetaiotaomicron Proteins
Preceding the pNP-carbohydrate functional assay of BT proteins extinction coefficients for

para-nitrophenol at each of the pH values being tested were generated. A series of kinetic and
functional assays were run on the B. thetaiotaomicron enzymes BT2857, BT3158, and
truncated/mutant truncations of BT2857. The first parameter tested was the pH at which BT2857,
BT2857 truncations, and BT3158 achieved optimal activity against the substrate 4-nitrophenyl-βD-galactopyranoside. It was found that BT2857 and both BT2857 truncations had maximal activity

pH8.4, while BT3158 was found to be most active at pH8 (Figures 23 - 24). Activity of the
enzymes against the substrate was confirmed using protein that was expressed in lacZ-deficient E.
coli Tuner(DE3) cells, as this cell line lacks an endogenous β-galactosidase that may contribute to
background pNP-β-D-galactosidase hydrolysis. Enzymes were also tested against the substrate 4nitrophenyl-ɑ-D-galactopyranoside at pH8.4 for BT2857 constructs and pH8.0 for BT3158, which
did not yield absorbance increases above background. pH ranges displayed were limited to 5.8 –
9.2 as at pH values higher or lower than resulted in visible precipitation of protein out od solution.
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Figure 23. pH Optima Kinetic Assay of Full-Length and N/C-Terminal Truncations of
BT2857. Triplicate reactions were conducted in a McIlvaine buffering system up to pH8.0
and 100mM phosphate buffer at pH 8.4 - 9.2 with 1mM pNP-β-Gal substrate and a final
concentration of 25μM for each protein. Final volume of each reaction was 250μL at a
temperature of 22°C.
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Figure 24. pH Optima Kinetic Assay of BT3158. Triplicate reactions were conducted in a
McIlvaine buffering system up to pH8.0 and 100mM phosphate buffer at pH 8.4 - 9.2 with
1mM pNP-β-Gal substrate and a final protein concentration of 5μM. Final volume of each
reaction was 250μL at a temperature of 22°C.
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Following pH optima analysis of BT2857, BT2857 truncations, and BT3158, MichaelisMenten kinetic assay of both full-length constructs and BT2857 truncations was done, as well as
for three mutants of BT2857C: D239A-D242A, D256A, and H300A-D304A. The MichaelisMenten curves for the tested proteins can be seen in Figures 25 - 26.
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Figure 25. Michaelis-Menten Analysis of BT2857 and BT2857 Truncations. Reactions
totalled 250μL with each protein being present at a final concentration of 5μM and were
conducted in triplicate. Solutions were buffered with 100mM phosphate at pH 8.4 and a
temperature of 22°C. BT2857 was determined to have a Vmax, KM, and kcat of 2.32x107
moles/min (±3.83x10-9), 0.13mM (±0.010), and 0.046s-1, respectively. BT2857N was
determined to have values of 2.29x10-7moles/min (±6.59x10-9), 0.07mM (±0.012), and
0.046s-1; while BT2857C generated values of 5.31x10-8moles/min (±8.09x10-10), 0.047mM
(±0.005), and 0.011s-1.
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Figure 26. Michaelis-Menten Analysis of BT3158. Reactions totalled 250μL with protein
being present at a final concentration of 5μM and conducted in triplicate. Solutions were
buffered with 100mM phosphate at pH 8.0 and a temperature of 22°C. BT3158 was determined
to have a Vmax, KM, and kcat of 6.06x10-6moles/min (±1.7x10-7), 0.052mM (±0.007), and 1.21s-1,
respectively.
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Figure 27. Michaelis-Menten Analysis of BT2857C Mutants. Reactions totalled 250μL
with each protein being present at a final concentration of 5μM and were conducted in
triplicate. Solutions were buffered with 100mM phosphate at pH 8.4 and a temperature of
22°C. All proteins had a final concentration of 5μM. Un-mutated BT2857C included to
illustrate increased catalytic rates of mutants. BT2857CD256A mutant showed values of 1.1x107
moles/min (±2.94x10-9), 0.041mM (±0.008), and 0.022s-1 for Vmax, KM, and kcat, respectively.
BT2857CD239A/D242A mutant showed values of 2.2x10-7moles/min (±6.33x10-9), 0.068mM
(±0.012), and 0.044s-1; while the BT2857CH300A/D304A mutants showed values of 3.11x107
moles/min (±6.96x10-9), 0.108mM (±0.012), and 0.062s-1 for Vmax, KM, and kcat.
BT2109 was also tested against the substrate analogue 2-nitrophenyl-β-D-galactopyranoside,
though Tuner-based expression of the protein failed to yield sufficiently pure protein to conduct
confirmation assays. Preliminary analysis however showed activity against this substrate analog
however, seen in Figure 28.
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Figure 28. Michaelis-Menten Analysis of BT2109. Reactions totalled 250μL with each
protein being present at a final concentration of 1.3μM and conducted in triplicate. Solutions
were buffered with 100mM phosphate at pH 8.0 and a temperature of 22°C. BT2109 was
determined to have a Vmax, KM, and kcat of 6.67x10-7moles/min (±1.29x10-7), 0.94mM (±0.51),
and 0.51s-1, respectively.
Following testing of the enzymes against analog nitrophenyl-carbohydrate substrates the fulllength enzymes BT2857 and BT3158 were tested against a variety of natural substrates containing
galactose via incubation at optimal buffer/pH conditions, with degradation/modification assessed
via TLC. Of the various carbohydrates tested, BT2857 showed degradative capability against ɑlactose, with the migration of the upper spot corresponding to galactose, while the second spot
migrated a shorter distance suggesting the other product is less polar than either glucose or
galactose. Analysis of digestions conducted with C- and N-terminal truncations showed that the
N-terminal DUF4959/DUF5126-containing domain was also capable of degrading ɑ-lactose,
while the C-terminal DUF5000-containing domain was not. Digestions conducted with BT3158
against ɑ-lactose showed similar results to those of BT2857, suggesting the enzymes work through
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the same catalytic mechanism. TLC results for the various digested products can be seen in Figures
29 - 30.

BT3158 + lac

Boiled BT3158 + lac

lac

galactose

glucose

Figure 29. Thin-Layer Chromatography Analysis of BT2857, BT2857N, BT2857C
Incubated with ɑ-lactose. Incubations were conducted in phosphate buffer at pH 8.4, 37°C,
under agitation. A) shows BT2857 incubated with lactose with reactions arrested at 30, 60,
and 120min. B) shows BT2857 truncations incubated overnight.

Figure 30. Thin-Layer Chromatography Analysis of BT3158 Incubated with ɑ-lactose.
Incubations were conducted in phosphate buffer at pH 8.0, 37°C, under agitation for 18 hours.
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Further attempts at characterizing the products of BT2857/carbohydrate digestions were
pursued in order to attempt to elucidate the identities of the spots seen on the TLC plates. Products
were extracted from the TLC plates through scraping of the silica and immersion in methanol to
desorb the carbohydrates from the silica. Silica was removed via centrifugation and methanol was
evaporated from the samples before dilution of the samples in D2O. NMR was then conducted on
samples. The results of NMR analysis can be seen in Figure 31 - 35.

Figure 31. 13CNMR of Lower Scrape from Lactose Digestion TLC. Spectra showed a total
of 20 signals, too great a number to come from a single monosaccharide. The presence of a
signal within the ester range of 160 – 185 ppm suggested the sample may be contaminated
with undigested lactose, or that the protein modifies lactose without breaking the ester bond.
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Figure 32. 13C NMR of Upper Scrape from Lactose Digestion TLC. Spectra showed far
smaller signals between 55 and 100ppm. Noteworthy is that certain signals appeared
upshifted relative to the other isolated product in Figure 27, including the possible ester
signal.

Figure 33. 1D 1H NMR of Lower Scrape from Lactose Digestion TLC. Mass of signals
integrated as 32.1 were not able to be correlated to structural features and may require higherfield NMR to resolve. The most down-field signal appears to indicate a CH2 group in the
product.
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Figure 34. 1H NMR of Upper Scrape from Lactose Digestion TLC. Of note are the signals
much further up-field not seen in the product isolated in the lower scrape, and the variation in
splitting in the 3 – 4ppm signals.

Figure 35. HMBC NMR Spectra of Lower Scrape from Lactose Digestion TLC. Analysis
most notably seems to suggest the presence of a methanediyl group next to an ester bridge in
the product. This
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4.4

Crystallization and Diffraction of Selected Targets
Preliminary crystallization of the BT2857C construct was achieved by a previous MSc

student (Maria Ngo) and conditions were expanded on in hanging drop expansions plates. Crystal
morphology was varied between thin platelets, platelet clusters, and thick plates, with the thick
plate crystals having enough 3-dimensional character to be appropriate for diffraction. Protein
purified from cells expressed in selenomethionine-containing minimal media were crystallized in
identical conditions to those of native crystals yielding 1.4Å resolution (Figure 36).
A)

B)

C)

Figure 36. Optimized Crystals and Example Diffraction Pattern for BT2857C. Optimal
reservoir conditions included: 0.1M sodium acetate buffer at pH 5.0; 6% (w/v) PEG 3.35K;
2% (w/v) glycerol; 0.2M ammonium acetate. Drops contained 1.5μL 25mg/mL protein and
1.5μL reservoir solution. A) shows crystal generated with protein derived from cells grown in
LB culture, while B) shows selenomethionine-containing crystals. C) shows an example
pattern taken from native-crystal diffraction to approximately 1.4Å resolution.
Preliminary crystallization was achieved for BT2857, BT2966, BT3158, BT2857CD256A, and
BT2857CH300A/D304A double mutant in sitting-drop vapour-diffusion plates. The BT2857 crystal
morphology was entirely thin needle-like or thin plate-like. Attempts at expanding these conditions
in hanging-drop expansion plates only led to thin needles and platelet clusters, with no diffractionquality crystals formed (Figure 37).
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A)

B)

C)

Figure 37. Initial Crystallization Hits and Hanging-Drop Optimization Attempt BT2857.
Initial hit A) was generated in MCSG-II well A1 with a reservoir mixture of: 0.2M Potassium
tartrate and 20% (w/v) PEG3350; with drop containing 0.5μL 30mg/mL protein + 5mM
lactose mixed with 0.25μL reservoir solution. Initial hit B) was generated in MCSG-II well
A12 with precipitant mixture of: 0.1M sodium citrate:citric acid pH5.5 and 40% (v/v)
PEG600. Hanging-drop crystals in C) were generated based on conditions in initial hit A) and
were not of diffraction data assessment quality.
BT2966 formed both small single plate and rod crystals in one sitting-well drop. These crystals
failed to be reliably replicated in hanging-drop expansion plates, and crystals taken from the
sitting-drop plates showed low resolution during diffraction and as such could not produce an
acceptable electron density map to build a model (Figure 38).
B)

A)

Figure 38. Initial Crystallization Hit for BT2966 and Corresponding Diffraction
Pattern. A) Crystals formed in a single sitting drop condition (Molecular Dimensions PACT
premier HT-96 well A6) with precipitant mixture containing: 0.1M SPG buffer at pH9.0; 25%
w/v PEG1500. Drop consisted of 0.3μL protein at 20mg/mL and 0.2μL reservoir solution.
Red arrow in B) indicates the diffraction spot that corresponds to the 7.52Å measurement in
the lower left-hand corner of the image.
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BT3158 formed crystals in several sitting-drop conditions, with low precipitant and good 3dimensional character. These conditions were expanded successfully in hanging-drop expansion
plates. Co-crystallization with carbohydrates that may bind the enzymes active site was also
attempted in hanging-drop plates (Figure 39). Preliminary statistics for the diffraction maps
generated from these crystals can be found in Appendix 7.

A)

B)

C)

Figure 39. Initial Crystallization and Examples of Optimized Crystallization and
Diffraction of BT3158. An initial crystal hit of favourable morphology was found in MCSGI well C7 with a reservoir condition of: 0.2M CaCl2; 0.1M Tris:HCl buffer pH 8.5; 25% w/v
PEG4000; drops contained 0.5μL 20mg/mL protein + 5mM DTT, 0.25μL reservoir solution.
A) depicts the initial sitting-drop; B) an expanded hanging-drop crystal of BT3158; C) an
example diffraction pattern, with red arrow indicating dot corresponding to 2.00Å.

BT2857CH300A/D304A double mutant formed a single crystal in preliminary sitting-drop screening,
alongside a significant amount of precipitate (Figure 40). The protein failed to be expanded on in
hanging-drop plates, producing significant amounts of precipitate.
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Figure 40. Crystallization of BT2857C H300A/D304A Mutant in Sitting Drop. Crystal
was formed in MCSG-I sitting-drop condition A12 with reservoir condition of: 0.2M CaCl2;
0.1M Tris:HCl pH 8.5; 20% w/v PEG4000; drops contained 0.3μL protein at 15mg/mL and
0.3μL reservoir solution.
Preliminary crystallization and hanging-drop expansion of PGN1176 was achieved in
number of different sitting-drop conditions, and these conditions were successfully expanded in
hanging-drop plates. Examples of the best crystal morphologies and preliminary diffraction
patterns can be seen in Figure 41. Further crystallization attempts under conditions that generated
favourable crystal morphology were pursued, however maximum resolution yielded by these
crystals was limited to approximately 7.11Å.
A)

B)

C)

Figure 41. Crystallization of PGN1176 and Sample Diffraction Pattern. Crystals in A)
were formed in MCSG-I sitting-drop condition B10 which contained: 0.16M MgCl2; 0.08M
Tris:HCl pH 8.5; 24% (w/v) PEG4000; 20% (v/v) glycerol; drops contained 0.5μL protein
solution at 20mg/mL and 0.25μL reservoir solution. Crystals in B) were generated in hanging
drops based on conditions in A). C) depicts a sample diffraction pattern for a crystal from
drop in B), with red arrow pointed to spot corresponding to 7.11Å resolution.
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Preliminary attempts at crystallization of PGN1459 in sitting-drop plates yielded several crystals
of good morphology in conditions containing high concentrations of sodium citrate, however the
diffraction patterns for them made it apparent the crystals were salt rather than protein. One other
crystallization condition containing 20% (w/v) PEG3350 as the main precipitating agent and a low
concentration of sodium tartrate was subsequently optimized upon in expansion plates. Crystals
and a preliminary diffraction pattern can be seen in Figure 42.

A)

B)

C)

Figure 42. Crystallization of PGN1459 and Sample Diffraction Pattern. A) shows crystals
generated in MCSG-II well E9 0.1M CHES:NaOH pH 9.5 and 1M sodium citrate, 0.3μL
15mg/mL protein + 0.3μL reservoir solution droplet, and the corresponding diffraction pattern
generated from a crystal in this drop. C) shows crystal formed in MCSG-II well F12, 0.3μL
15mg/mL protein + 0.2μL reservoir solution (0.2M sodium tartrate dibasic; 20% (w/v)
PEG3350) droplet.

Preliminary crystallization of PGN1461 in sitting-drop plates was achieved by a colleague
(Katarina Mandić) and the conditions for subsequent hanging-drop expansion plates that yielded
diffraction-quality crystals were co-designed. The preliminary statistics for diffraction of these
crystals taken from these hanging-drop conditions can be seen in Appendix 7.
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4.5

Mutagenesis of BT2857C and Truncation of DUF4959
Mutagenesis of BT2857C was initially undertaken as it was assumed that the DUF5000

domain would be the catalytically-active portion of the protein. Residues were identified both
through multiple sequence-alignment of target proteins in the case of BT2857N and coordination
of ethylene glycol molecules in X-ray diffraction structures in the case of BT2857C. These
multiple sequence alignments and coordinated residues interacting with ethylene glycols can be
seen in Figure 43 - 44.
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Figure 43. Multiple Sequence Alignment of DUF4959/5126 Domains from Conserved
Putative Galactosidases from B. thetaiotaomicron. Sequences were aligned using the
Clustal Omega online resource. Residues of high conservation and/or interest highlighted for
clarity.
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Figure 44. Coordinated Ethylene Glycol Molecules in BT2857C Crystal Structure.
Protein structure figure generated in UCSF Chimera and residue labels added in Adobe
Photoshop. Ethylene glycol molecules indicated by red arrows.
Residues were selected for mutagenesis in BT2857C based on them both lining the trench motif
and being likely charged charged. Generation of the mutants BT2857CD239A/D242A, BT2857CD256A,
and BT2857CH300A/D304A was done by Darryl Jones at Lethbridge Research and Development
Centre, Agriculture and Agri-Food Canada. Mutagenesis of BT2857C to BT2857CD239,
BT2857CD242A, BT2857CH300A, BT2857CD304A, and BT2857N to BT2857ND35A, BT2857ND37A,
BT2857ND83A, and BT2857NR84A was pursued at Wilfrid Laurier University using Phusion HighFidelity polymerase with the SOMA-type protocol. Forward and reverse primers used in
mutagenic trials can be seen in Appendix 4. Following DpnI digestion of PCR reactions agarose
gel analysis was done to assess the success of the trial. Results of these analysis can be seen in
Figure 45 and 46.
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Figure 45. Agarose Gel Analysis of BT2857N SOMA Mutagenesis Post-DpnI Digestion.
0.7% (w/v) gels loaded with 6μL of sample containing 5μL PCR sample and 1μL NEB 6x
Purple Gel Loading Dye. Details in parenthesis indicated deviations from standard procedure.
“- f” and “- r” suffix indicates whether a forward(f) or reverse(r) primer was used in the
reaction. Bands in the 5000 – 5500bp range indicate successful mutagenic replication of the
plasmid. Ladder used was NEB Quick-Load Purple 1kb DNA Ladder.

6kb
5kb
4kb
3kb
2kb

D239A - f

1kb

Figure 46. Agarose Gel Analysis of BT2857C SOMA Mutagenesis Post-DpnI Digestion.
0.7% (w/v) gels loaded with 6μL of sample containing 5μL PCR sample and 1μL NEB 6x
Purple Gel Loading Dye. Band and the 5500bp range indicate successful mutagenic
replication of the plasmid. Ladder used was NEB Quick-Load Purple 1kb DNA Ladder.
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The D37A mutant for BT2857N showed single banding and was directly transformed into DH5ɑ
E. coli cells. BT2857CD35A, BT2857ND83A, and BT2857NR84A mutant plasmids (Figure 44, 45)
were extracted and purified from agarose gels with QIAquick gel purification kits prior to
transformation. Transformed cells were streak plated on agar containing 100μg/mL ampicillin and
colonies were picked to generate 5mL minicultures. Minicultures were miniprepped and plasmids
sent to Robarts Research Institute (University of Western Ontario, London, ON, Canada) for
bidirectional sequencing. BT2857ND37A and BT2857NR84A and BT2857CD239A mutants were
determined to have been successfully generated; amino acid sequence results can be seen in
Appendix 5.
Truncation of DUF4959 from BT2857N and BT3158 were pursued, firstly in order to
determine if this domain was the site of catalysis for the enzymes, and secondly for attempts at
crystallization in the hopes that a full structural characterization could be made for the enzymes.
The initial step in the truncation process involved amplifying the gene sequence from the plasmids
that contain them. Bestaq 2x Mastermix was used with standard amplification protocol. PCR was
performed with a primer that complemented the plasmid upstream of the inserted gene, and a
primer that complemented the terminus of the DUF4959 sequence and contained the sequence for
the NdeI cut site downstream of this terminus. Primers used in the initial amplification of the gene
sequence can be seen in Appendix 4. Initial amplified targets can be seen in Figure 47. Successfully
amplified targets were purified using QIAquick PCR Purification kit before digestion.
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Figure 47. Agarose Gel Analysis of BT2857N/BT3158-DUF4959 Amplification. 0.7%
(w/v) gels loaded with 6μL of sample containing 5μL PCR sample and 1μL NEB 6x Purple
Gel Loading Dye. Ladder used was NEB Quick-Load Purple 100bp DNA Ladder.
Purified targets were digested using XhoI and NdeI, as was pET21b(+) with the addition of BamHI,
and purified using QIAquick PCR purification kit. Targeted insertion sites XhoI and NdeI on
pET21b(+) can be seen in Appendix 6. Digested and purified products can be seen in Figure 48.
pET21b(+) showed an apparent increase in base-pair size, which is like attributable to the

BT3158

BT2857N

pET21b(+) undigested
pET21b(+) digested

linearization of the plasmid(124).

Figure 48. Agarose Gel Analysis of pET21b(+) and BT2857N/BT3158-DUF4959
Digestions. 0.7% (w/v) gels loaded with 6μL of sample containing 5μL PCR sample and 1μL
NEB 6x Purple Gel Loading Dye. Ladders used were NEB Quick-Load Purple 100bp DNA
Ladder and NEB Quick-Load Purple 1kb DNA Ladder.
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BT3158-DUF4959, showing predicted decrease in apparent base-pair size after digestion, was then
used in ligation with cut pET21b(+). Ligations were done at 1:3 and 1:5 vector:insert molar ratios.
Transformation of ligation reactions into competent DH5ɑ E. coli cells yielded 3 colonies on
ampicillin-containing agar plates, but none of the colonies were able to grow in ampicillincontaining minicultures, indicating the ligations likely failed.
4.6

Preliminary Functional Analysis of PGN1459
As bioinformatics analysis and literature had indicated that PGN1459 was likely to interact

with the genomic DNA of P. gingivalis, the protein was tested against several plasmid samples in
order to assess this possibility. 50μL of DNA/buffer solution were initially made containing: 20ng
of DNA, NEB CutSmart buffer, alkaline phosphatase buffer, and T4 Ligase buffer. 50μL samples
were split into two 25μL samples before 1μL of 17.34mg/mL PGN1459 was added to one of the
samples. Reaction were incubated for 18 hours, under agitation, at 16°C. Agarose analysis of the
results of this can be seen in Figure 49. pET21b(+)-BT2857N, pET21b(+)-3158, and pET28aBTLip lanes did not show banding for both the control and +protein samples and thus were not
considered in analysis. Lanes that contained pET21b(+), pET15-BT2857, and pET21b(+)BT2857C samples all showed disappearence in banding in wells that contained DNA+PGN1459
protein, suggesting some type of interaction between protein and DNA is occuring preventing the
DNA from migrating on the gel. As the protein has a theoretical pI of 5.03 it ought to be negatively
charged at the agarose gel pH of 8.3, and thus if it is bound to the DNA it should not cause
migration towards the negative electrode. Further analysis will be needed to confirm the mode of
interaction between protein and DNA.
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pET28a-BTLip + p
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Figure 49. Agarose Gel DNA-Shift Analysis of PGN1459 and Selected Plasmids. 0.7%
gels loaded with 12μL of sample containing 10μL PCR sample and 2μL NEB 6x Purple Gel
Loading Dye. Ladders used were NEB Quick-Load Purple 100bp DNA Ladder and NEB
Quick-Load Purple 1kb DNA Ladder. Labels containing the “+ p” designation indicate which
lanes were loaded with samples that contained protein, while labels without “+ p” indicate
protein-free controls.
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CHAPTER 5 - DISCUSSION
5.1

Structural and Functional Characterization of BT2857 and BT3158
The first objective of this research was the structural and functional characterization of the

homologous, putative carbohydrate-active enzymes from the symbiotic gut microbe B.
thetaiotaomicron in order to assign function to the Domains of Unknown Function (DUF) that
make up these proteins, determine active-site residues and add to both the understanding of the
pathways that regulate carbohydrate metabolism in BT and general knowledge of protein structure
and function. The specific targets chosen for study in this case were: BT2109, BT2857, BT2918,
BT2966 and BT3158, all of which are conserved in position on various polysaccharide-utilization
loci within the genome of B. thetaiotaomicron. Full-length constructs BT2109, BT2857, BT2966,
and BT3158 were successfully expressed, purified, and concentrated for kinetic characterization
with the substrate mimicking compounds 4-nitrophenyl-β-D-galactopyranoside and 4-nitrophenylɑ-D-galactopyranoside. From the generated Michaelis-Menten curve the Vmax values for BT2857,
BT2857N, and BT2857C were determined to be 2.32x10-7moles/min, 2.29x10-7moles/min, and
5.31x10-8moles/min, respectively at pH 8.4 and 22°C. kcat for each construct was determined to be
0.046s-1 for both BT2857 and BT2857N, while BT2857C had a value less than ¼ the size, at
0.01s-1. KM values for BT2857 and N/C-terminal truncations were determined to be 0.13mM,
0.07mM, and 0.047mM, respectively. Of note were the similar catalytic rates possessed by fulllenth BT2857 and its N-terminal truncation, suggesting that the C-terminal domain does not
enhance enzyme activity against the pNP-β-Gal substrate analog. BT3158 generated much higher
kinetic values from Michaelis-Menten analysis: 6.06x10-6moles/min, 0.052mM, and 1.212s-1 for
Vmax, KM, and kcat respectively at pH 8.0 and 22°C. Tuner cell-based expression of the constructs
confirmed that the constructs possessed β-galactosidase activity as the particular cell line lacks any
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genes coding for endogenous β-galactosidases that may cause background hydrolysis of the pNPβ-Gal substrate analog. Testing of the enzymes BT2857, BT2857 truncations, and BT3158 against
the substrate analog 4-nitrophenyl-ɑ-D-galactopyranoside did not show any increase in absorbance
above background, demonstrating that the enzymes are selective for carbohydrates containing
galactose in β-conformation. BT2109 and showed activity against the substrate pNP-β-D-Gal in
preliminary testing, though Tuner-cell expressed-protein controls were not able to be run and as
such catalysis from the endogenous β-galactosidase coded for by E. coli may have been
present(125). Vmax, KM, and kcat were determined to be 6.67x10-7moles/min, 0.94mM, and
0.513s-1 for this protein. Most striking from the various kinetic analysis was the apparent
stimulation of catalytic activity in mutants of the BT2857 C-terminal truncation, with the double
mutants D239A/D242A and H300A/D304A showing catalytic rates comparable to that of the fulllength enzyme. While this domain of the enzyme was hypothesized to be a carbohydrate-binding
module based on the initial comparison of construct catalytic rates, these mutants seem to suggest
that the DUF5000 may have some suppressed catalytic activity against (R)-β-D-galactosecontaining substrates. TLC analysis showed that both BT2857 and BT3158 have activity against
the disaccharide ɑ-lactose, which contains a galactose β-bonded to a glucose monomer. Analysis
of BT2857 truncations showed that the N-terminal DUF4959/5126 domains had degradative
activity against ɑ-lactose, while the DUF5000-containing C-terminal truncation showed no
degradative capability. Characterization of the products via NMR analysis revealed a likely ketose
group in the product that migrated less quickly on the TLC plate. Contamination with TLC solvent
was ruled out due to 1-butanol and acetic acid not containing ketose groups.
Initial crystallization of several BT proteins was achieved in sitting-drop trays although
few conditions yielded diffraction-quality crystals in hanging-drop plates. High-quality crystals of
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BT2857C and BT3158 were generated however, and high-resolution diffraction data for these
proteins was collected.
Modification of the nucleotide sequences of genes coding for BT2857 and BT3158 through
truncation and site-directed mutagenesis was pursued in order to elucidate active-site residues,
confirm functionality of DUF4959, and build a full crystal structure of at least one of the proteins.
Multiple sequence alignment of the DUF4959/5126 sequences from the homologous targets
revealed several conserved charged residues, which were decided on as targets for mutagenesis.
The amino acid residues in the putative substrate-binding trench of BT2857C were also selected
as potential targets. Successful mutagenesis of aspartate 37, arginine 84, and aspartate 239 were
achieved through single-oligonucleotide mutagenesis and validated at the Robarts Research
Institute. Full truncation and expression of the DUF4959 domain was not fully successful, however
it was shown that the amplification, restriction endonuclease digestion, and purification of the
DUF4959 gene fragment was achieved.
5.2

Bioinformatics Analysis and Characterization of P. gingivalis Proteins
The second objective of this research was to characterize proteins from the oral pathogen

P. gingivalis that were found to be upregulated during biofilm colonization in order to build a
better model of periodontal disease, identify possible novel therapeutic targets to mitigate the
virulence of P. gingivalis, and add to the collective knowledge on protein structure/function.
5.2.1 PGN1176
PGN1176 was assessed via bioinformatics analysis to very likely be cytoplasmic-localized
3-hydroxybutyryl-CoA dehydrogenase enzyme necessary for catalyzing the reaction: (S)-3hydroxybutanoyl-CoA + NADP(+) ↔ 3-acetoacetyl-CoA + NADPH (126). As P. gingivalis is a
microorganism that prefers to use amino acids as a source of carbon and energy(94), this enzyme

91

is likely not involved in energy metabolism, but rather in pathways necessary for the formation of
short-chain carboxylic acids that will eventually be exported extracellularly(127). The export of
these short-chain carboxyl species, particularly propionate and butyrate, is strongly associated with
progression and relative severity of periodontal disease(128). Volatile fatty acids such as those
produced by the pathways PGN1176 involved in, have been shown to cause suppression of the
host immune system by inducing apoptosis in B- and T-cells(129, 130) as well as penetrate
epithelial tissues and induce an inflammatory response(131). The FadB region in the protein also
suggests that the protein may be involved in stationary-phase survival, as Fad genes are frequently
associated with energy scavenging and production under starvation conditions in other
organisms(132).
Several protein crystallisable conditions showing appropriate morphology for PGN1176
were identified through sitting-drop vapour-diffusion screening. Certain expanded conditions
yielded several crystals that, via visual inspection, appeared to be of diffraction quality, while also
not requiring submersion in cryoprotectant solution prior to freezing in liquid nitrogen, though
these crystals diffracted at resolutions ~7Å and above.
5.2.2 PGN1459
PGN1459 was chosen as a target for investigation based on its relationship to PGN1461
and literature on the YicC domain it contains. YicC proteins (typically referred to as OrfX in
previous literature(133, 134)) have been shown to be part of a complement of genes involved in
stress-response essential for survival and normal cell morphology in stationary phase at high
temperature (37°C - 45°C)(135). This fact is physiologically important as the human body falls
within this temperature range and growth of microorganisms within a biofilm can be comparable
to growth during stationary phase conditions in some ways(136). One knockout study on P.
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gingivalis where Universal Stress Protein A (UspA) had been removed from the genome found
that biofilm formation and general survivability under stress was reduced as compared to the
parental strain of the organism(137). While the function of both of these proteins is unknown(132),
it does illustrate that a stress-response protein can play a significant role in the persistence and
pathogenicity of P. gingivalis during growth in a biofilm.
In the preliminary functional assay of PGN1459, lanes in the agarose gel loaded with
sample that contained both DNA and the purified protein had banding disappear. This likely cannot
be explained with the protein binding the DNA and migrating towards the negative electrode and
off the gel as, like with DNA, PGN1459 should carry a negative charge at the pH of the TAE
buffer (~8.3) due the protein having a theoretical pI of 5.03. The second attempt of this crude shifttype assay omitted the heat-arrest, and so precipitation of the DNA out of the solution along with
the protein also does not explain the absence of banding in the protein-containing wells.
5.2.3 PGN1461
PGN1461 was assessed via bioinformatics analysis to be a trimeric gate protein localized
to the cytoplasmic membrane, though the specific type of transporter, and thus the (type of)
substrate the protein is specific to, could not be determined. Three candidates for the type of
transporter were, however, able to be identified through sequence-based homology analysis: FeoBtype Fe2+ GTPase transporter, NupC-type concentrative nucleoside permease, and AbgT-type
aminobenzoyl-glutamate transporter. The possibility of the protein functioning as an iron
transporter is based on InterPro and BLASTp, analysis which indicated the presence of two FeoBtype gate domains in the protein. This is a significant possibility as FeoB transporters have a high
affinity for Fe2+ (138) and iron uptake has been shown to be a high priority for P. gingivalis, which
contributes greatly to the survival and pathogenicity of the organism(89, 139, 140). The second
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possibility, with PGN1461 working as a concentrative nucleoside permease powered by proton
symport(141) is based on the top two results for template possibilities according to Phyre2 analysis.
Literature is less clear regarding the importance of nucleosides in the survival and virulence of P.
gingivalis, though it has been suggested previously they may be used as: A) precursors in amino
acid biosynthesis, or B) carbon sources(95). Under certain conditions, genes involved in the
scavenging, biosynthesis, and transmembrane transport of nucleotides are seen to be upregulated
as well(86, 142), indicating that nucleotide/nucleoside metabolism likely plays some role in the
survival of P. gingivalis. Thirdly, the possibility of AbgT-family membership was based on the
top RaptorX template result (PDB ID: 4R1I) and #3 and #4 ranked Phyre2 templates (PDB IDs:
4R1I, 4R0C). Members of this family of transporters have shown multitude of possible functions,
including: importing aminobenzoyl-glutamate, exporting aminobenzoate, and operating as an
efflux pump for sulfonamide antibiotics(143). If PGN1461 were to have any of these functions
persistence and virulence would be affected: para-aminobenzoate and para-aminobenzoylglutamate are precursors used in the biosynthesis of essential folate and folate-based vitamins and
elevated levels of these compounds have been shown to increase the survivability and colonization
of P. gingivalis in mouse models(144); the presence of an antibiotic efflux protein increases the
survivability of the organism(121).
PGN1461 was found to be more effectively bound by anion-exchange resin than cationexchange resin during FPLC purification despite the theoretical pI of the protein being 8.97, as
determined by the ExPASy ProtParam resource. This suggests the protein has a higher proportion
of negatively-charged surface residues accessible by the resin, at operating pH of 7.5, than the
theoretical pI would suggest. The apparent negative nature of the protein surface may be indicative
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of preference for positively-charged species, as surface charge compensation has been previously
be seen to be one of the mechanisms employed by certain metal transporters(145).
Successful crystal screening, optimization, cryoprotection, and diffraction of PGN1461
was conducted, with good preliminary data processing for the crystals (Appendix 7).
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CHAPTER 6 - CONCLUSIONS AND FUTURE DIRECTIONS
6.1

B. thetaiotaomicron Proteins
Bioinformatics analysis predicted each protein in the selected B. thetaiotaomicron PULs

would possess three conserved domains of unknown function: 4959, 5126, and 5000. DUF5000
was thought to be the most likely site of catalysis due to its homology to galactose-binding like
domains. Through kinetic characterization the target proteins BT2109, BT2857, BT2966, and
BT3158 all possessed catalytic activity against the substrate-analog 4-nitrophenyl-β-Dgalactopyranoside which partially illuminates the functionality of these proteins. The proteins
BT2857 and BT3158 were tested against the substrate 4-nitrophenyl-ɑ-D-galactopyranoside,
which showed no activity, confirming stereochemical-specificity of the proteins at least against
galactose-containing disaccharides. For BT2857, a Vmax of 3.19x10-7M/min, KM of 1M, and kcat of
0.001s-1 was calculated through Michaelis-Menten analysis, while BT3158 showed far more
effective catalysis with values of 8.67x10-6M/min, 1M, and 0.029s-1 for Vmax, KM, and kcat,
respectively. The C-terminal truncation of BT2857 had values of 7.64x10-8M/min calculated for
Vmax, 1M for KM, and 0.00025s-1 for kcat, while the N-terminal truncation had values of 3.30x107

M/min, 1M, and 0.001s-1. This revealed that contrary to the hypothesis that the C-terminal

DUF5000 domain would be primarily responsible for catalysis in the protein, the N-terminal
domains DUF4959 and DUF5126 appear to be responsible for breakdown of saccharides
containing β-galactose. Mutations of BT2857C showed increased activity against the substrate
pNP-β-Gal, possibly suggesting the DUF5000 domain may have some suppressed CAZyme
activity. TLC analysis of BT2857 and BT3158 revealed degradative capability against the
carbohydrate substrate ɑ-lactose, a disaccharide which contains a galactose in β-conformation. The
same analysis of BT2857N and BT2857C revealed that BT2857N is capable of degrading ɑ-
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lactose while BT2857C was not, further validating the notion that the DUF4959 and DUF5126
domains are primarily responsible for the breakdown of carbohydrates containing a β-conformed
galactose monosaccharide.
Full structural validation of homologous galactosidase structures was not able to be
achieved in the course of this research due to the poor electron density seen over the majority of
the DUF4959 domain in BT3158 despite the high-resolution data (Appendix 7). Truncation and
crystallization of this domain from BT3158 will be required to obtain a fully-validated structure
for one of the selected BT proteins. Co-crystallization of the proteins with substrates and/or
substrate analogs would also be assistive in the analysis of individual binding sites within
crystallized BT proteins. Further TLC functional analysis of the proteins using trisaccharides
should be done to further assess the degradative capabilities of the proteins, and Michaelis-Menten
analysis of BT2857N point mutants would also identify if the targeted amino acid residues are
catalytically important.
6.2

P. gingivalis Proteins
Bioinformatic and literature research was able to validate the putatively role of the likely

biologically significant factors selected for study, with each protein selected being expected to
serve to either increase the pathogenicity or general fitness of P. gingivalis in ways that fit within
the context of previously characterized virulence pathways. PGN1176 likely plays a role in the
production of fatty acids involved in the suppression of host immune response; PGN1461 in the
uptake of metabolically necessary ions/compounds or efflux of antibiotics; PGN1459 in
maintaining cellular health and morphology under heat and stress. Each protein was successfully
expressed and purified to homogeneity for crystal tray plating, and some preliminary functional
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analysis was conducted, in order to reveal the structural and functional characteristics of the
targets.
Full structural validation of P. gingivalis target proteins was not able to be achieved over
the course of this research, however significant progress towards this goal was made. PGN1176
was able to be crystallized from both fresh and frozen stocks of protein, and currently has several
sitting-drop conditions that may be optimized in hanging drop plates, such that crystals that diffract
at high resolution may be generated, including those that are co-crystallized with NAD(P)+ and/or
acetyl-CoA. PGN1461 was managed to be crystallized and diffracted at acceptable resolutions
with good preliminary statistics. Due to the protein having low similarity with any other previously
characterized construct, experimental phasing will need to be pursued in order to solve the
structure. For experimental phasing both expression of the protein in selenomethioine-containing
media and soaking of native protein crystals with heavy atoms (particularly iron) should be
pursued. Co-crystallization of proteins with putative substrates, such as nucleosides and paminobenzoate/aminobenzoyl-glutamate should also be pursued. PGN1459 yielded a one
crystallization condition that appeared to be in fact sodium citrate crystals, and one condition
containing mainly PEG3350 as the precipitating agent. This PEG-containing condition permitted
the growth of only a single small crystal and should be further optimized in future attempts to solve
the structure of this unique, and poorly studied type of protein. Should optimization of PEG-based
crystallization be successful experimental phasing will be required to solve the structure of this
protein, as well as co-crystallization of protein with nucleotides/nucleosides.
All of the various P. gingivalis targets selected for study in will all require experimental
validation of function in order to confirm activity of the proteins and generate any kinetic constants
that may be associated with the type of reaction. In the case of PGN1176, function as either a 3-
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hydroxybutyryl-CoA dehydrogenase (EC: 1.1.1.157) or 3-hydroxyacyl-CoA dehydrogenase (EC:
1.1.1.35) will need to be determined, along with parameters such as KM and kcat. For PGN1461,
activity as either a Fe2+, nucleoside, or aminobenzoyl-glutamate transporter will need to be
determined in order to fit it into an improved model of periodontal disease being built. PGN1459
is a protein of truly unknown function, with little research into its mode of action or mechanism.
Based on previous literature and genomic context however, it likely interacts with DNA in some
fashion. Confirmation of protein-DNA interaction, and elucidation of the type/mechanism of
function will be required to determine what the role of the protein is in the cell.
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APPENDICES
Appendix 1: List of Bioinformatics Tools
Program
NCBI
BLASTp
EMBL-EBI
InterPro
UniProt

CAZy
Database

Kyoto
Encyclopedia
of Genes and
Genomes
ExPASy
ProParam
Phyre2

RaptorX
RCSB Protein
Data Bank
STRING
SignalP4.1

Information Provided
Runs a query sequence against a database of other
sequences to find local similarities as well as
annotated domains
Runs a query sequence and predicts domains,
families, superfamilies, signal regions, and motifs
through comparison to sequence databases
Provides amino acid sequences and links to
associated publications, database entries, and various
bioinformatics tools
Collection of information on hypothetical and
validated CAZymes
Links to characterized CAZymes within enzyme
families
Database of annotated genomes for various organism
and the genes contained within them
Links from genes/genomes to other bioinformatics
resources/databases
Computes various biophysical properties of
submitted amino acid sequences including: molecular
weight, theoretical pI, extinction coefficient, and
instability index score
Automated homology-modelling of amino acid
sequences to find likely 3-dimensional structure;
ranked list of previously-characterized template
proteins
Automated homology-modelling of amino acid
sequences to find likely 3-dimensional structure
Experimentally-determined 3-dimensional protein
structures and related publications/database links
Generates interactive maps of gene/protein
interactions around a central node gene
Predicts the presence and location of signal peptides
within submitted protein sequence

ExPASy
TMPred

Predicts areas of a protein sequence likely to traverse
a membrane bilayer

PSORTb

Predicts the subcellular localization of proteins based
on amino acid sequence
Aligns multiple amino acid sequences based on the
shared similarity

Clustal Omega
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Web Address
https://blast.ncbi.nlm.
nih.gov/Blast.cgi?PAG
E=Proteins
https://www.ebi.ac.uk
/interpro/
https://www.uniprot.
org/
http://www.cazy.org/

https://www.genome.
jp/kegg/

https://web.expasy.or
g/protparam/

http://www.sbg.bio.ic.
ac.uk/phyre2/html/pa
ge.cgi?id=index
http://raptorx.uchicag
o.edu/
https://www.rcsb.org/
https://string-db.org/
http://www.cbs.dtu.d
k/services/SignalP4.1/
https://embnet.vitalit.ch/software/TMPRE
D_form.html
https://www.psort.org
/psortb/
https://www.ebi.ac.uk
/Tools/msa/clustalo/

Appendix 2: Amino Acid Sequences of Protein Constructs
BT2109
- pET15b
- amp-resistant

BT2857
- pET15b
- amp-resistant

BT2857
N-terminal
truncation
- pET21b(+)
- amp-resistant
BT2857
C-terminal
truncation
- pET21b(+)
- amp-resistant
BT2918
- pET15b
- amp-resistant

BT2966
- pET28a
- kan-resistant

BT3158
- pET15b
- amp-resistant

PGN1176
- pET21b(+)
- amp-resistant

MKNIAFILLILAAVCFANCAGDYEAEPRGTNDGKAPAPITNISVKNVNGGAIIKYTPSDD
VDLLYVKAIFTNTRGEQQEVKSSMYVDSLVIEGLGDTQKREVKLYSVDRHENYSTPAIVT
IEPLTPAVVQTQESLKVTESFGGFFLDFNNAARSALSFYIYKWVDEHNEYEIHDVYSSQQ
EEGRLTIKGLEHKLLKLAIFVRDKWENTSDTLYAEITPWKESLLDKTKFQLVKVMDDVSW
DYHEGYHSRLWDGQIGGWNWGHTEYPIPFPHAFSIDLNVNVRLSQFQFWQRLDSQDLLYA
HGAPKYFKLYGCEEGKDLQNPDNWVVLFDGEMKKPSGGAFGDALTQEDIEEAQRGHVFTL
NQDVPFIRYFRFQSLMSWSGMETSVMSEITLWGDIQGEE
MISRKFTIWACGLLFVFGSCAEDMVKPIENDKDAPGTVQDVKTESLPGAVKFTYTLPSDP
DLLYVLAKYTNKTGKVMEFRSSFYTNSVTVEGFGDTDTYKVELYTVDRSENRSQPQIVEV
VPLTPPILSCYESLSMVSDFGGMTFEMDNKFKSDLAIYVCTPDELGDMVLAETFYSAREE
IVYSVRGYDAVPRRFGIFLQDKYGNETDTLFTELTPIYERELDKTKFREMYLQNDSRVDS
YDGKMEYVWNGRISKDGDSGGVGLHTGTGTKDGPAVFTFDLGVLAKLSRFALWAIQDEKH
FYNDMSPRRYEVWGCATEPNPDGSWDQWVKLLDMENVKPSGSPIGILTEDDIEAAKIGDQ
ANVPLDMPRVRYIRIKCLKNWSNNYNICFTELTFWGNDNEE
VKPIENDKDAPGTVQDVKTESLPGAVKFTYTLPSDPDLLYVLAKYTNKTGKVMEFRSSFY
TNSVTVEGFGDTDTYKVELYTVDRSENRSQPQIVEVVPLTPPILSCYESLSMVSDFGGMT
FEMDNKFKSDLAIYVCTPDELGDMVLAETFYSAREEIVYSVRGYDAVPRRFGIFLQDKYG
NETDTLFTELTPIYERELDKT

ELDKTKFREMYLQNDSRVDSYDGKMEYVWNGRISKDGDSGGVGLHTGTGTKDGPAVFTFD
LGVLAKLSRFALWAIQDEKHFYNDMSPRRYEVWGCATEPNPDGSWDQWVKLLDMENVKPS
GSPIGILTEDDIEAAKIGDQANVPLDMPRVRYIRIKCLKNWSNNYNICFTELTFWGND

MKKKLYKYGLLYIGVALAACADNADLNEPAGSTTPPAQVLNATVKNLPGAAIIYYDLPDD
QNLKYVRASYKVDNMVRTVNASFYTDSLVVEGFPTKGEYDIELYSVSYGEVVSSPLVVKV
NPDTPPYQKVRGTLVSAETFGGIRVNFDNPEKAKLGLGVIKKQAEGIWTQVYMHYTEAKG
GDFYVRGLDAVTTDFGIFVRDRWGHLSDTLYVTETPLYEEQCDKSLFRKMALPTDSYECH
SWNEVTKGNDMTRLWDGITDADPCFQTKTTTVMPQWFTFDMGENYKLSRFVMVSRYYPGK
YGNTFKAGHPKHFEIWGSINPNPDGSFDDSWVLLSEYESVKPSGGGVNDALTAEDQEAAK
NGENFIIPDNAPAVRYIRFRTNNTWGNTRYMHLHELTFFGAKHN
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DKNFLYMKAVYMTEIGERSTNASYFADSVVVEGFEKAGEYNVKLYSVSPGEAYSEPLEVK
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APNANTPKNLYDGIIGSNNTFMTLTTAGYDFTKPSSVTLDLGKKFKLSRMIVYGRRNGTD
YSSIFDGLYPKEIEIWGRNDNNVTKFDPENDEGWVRLYQGVLPRADGSVIPAAIVPLTDA
DKELARDGNELEFSVDLDAYRYVTFVCIKNYNVGTSRINVAELTFFGTPEDKIIQ
MKKRILYYIWIACAAVLLHSCEDVETHKPYGDGSGHAPGTVQVTSYEQIPGGVTLKFIAP
TDEDLLYIKIKYTLDNGKEMEARASLYTDETTIEGFGNTNPKKLVISAVNKMEKEGEAII
TEIVPGKPAYLTAIEEIEVNPTFGGIYIHTTNGGRNYLIFDVSTKDSKGNWNIEHTEYTS
VKNIGFTLRGFSAEPHDFKVRVRDLYDNQSEEYLTTLTPLYEEKLDLTKFKTFYLANDIK
MDNAGHTLESLFNGDHGLNSWNYAHGYDFNPSEFPVWFTFDMGQTAQLSRFTSWQRSMGG
SYYYRAGAIKEWEVWGRSDLPSSDGSWDGWTKLADCESIKPSGWPTGSNSEEDITYASKG
EEFEFLADIPPVRYIRFKILSTHDGAGLVVMQQLWFYGTPIQ
MKIAVVGTGAMGSGIVQCIAQNGLDVLMKGRSETSISKSLKGIEKNLNRLVEKGKMSADE
QQAVMARIRTTMDFNDLKDAGVVIEAIAEEMEIKKQALSAVAEVVSEQCIIATNTSSLSI
TALATELPTPSRVIGMHFFNPVPVMKLVEVISAQQTSDEVMKLVLDLCEMLKKTAVRVNE
APGFVVNRLLIPMINEGIGAYADGVASIEEIDQAMMLGANHPMGPLALGDFIGLDVCLAI
MEVLFTEFGDAKYRPHPLLRKMVRAGQLGRKTGKGFYDYSK
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PGN1459
- pET21b(+)
- amp-resistant
PGN1461
- pET21b(+)
- amp-resistant

MTGFGKHTIQFADKKITATIKSLNSKQFDLSTKISSRYRDRELPLRALVSADIRRGKVDL
SLFLEESGSTDVVSQIFDTEKMSSYFFQLKEFGEKMGVEVPAGGWFEQLLRIPGVIQIDE
DKEEEIPEDEWAVVIETCRRALDQLIGFREQEGAMLEQVFTEKISNISSLLLQIEQYEPE
RIQRIKERIEENLTKISEKDYDKNRFEQEMIYYIEKLDVNEEKHRLRNHLSYFLQTMQGE
PGQGKKLSFIAQEIGREINTLGSKSNHVEMQQIVVQMKDELEQIKEQVLNVL
MVLNYIFVAFFLVSLIVALVRLIAFGDVSVFDEMVQASFSQSKNAFEIALALTGVLALWL
GLMKIAERSGLISKLAQISSPVLSRLFPSVPKGHPALGNIFMNISANLLGLDNAATPLGI
RSMESLQTINQQKDKASDAMIMFLAINASGLTLIPSSIMAYRLQAGAANPADIFVPVLIA
TFASTLVAILAVGVKQRIDFFQKPLLLFLLSSLLFIGGVIYAGRTLPPETFSSISTAFAS
ILLFGIMCGFVVSGLRARINVYDAFIEGAKDGFGTAVTIIPYLLAMLVGIGIFRASGAMD
LITEGLRGLVGFWGGDMKFVEGIPTMLMKPLSGSGARGLMVDAMQTYGADSFVGRLCSIV
QGSSDTTFYVVALYYGAVKIRNTRYTVSYSLLADLAGALTAIAVTYIFFG

Appendix 3: ProtParam Outputs for Protein Constructs
Construct

Molecular
Weight (Da)

Residue
Number

Isoelectric Point

BT2109
BT2857
BT2857N
BT2857C
BT2918
BT2966
BT3158
PGN1176
PGN1459
PGN1461

45588.19
45578.32
22774.60
20327.78
45473.12
46565.60
45511.95
30362.61
34049.74
43658.65

399
401
201
178
404
415
402
281
292
410

4.81
4.59
4.42
4.87
5.47
4.99
4.98
5.76
5.03
8.97
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Extinction
Coefficient
(M-1cm-1)
87320
74175
19370
48930
81250
62230
94770
5960
21430
28880

Appendix 4: List of Primers for Site-Directed Mutagenesis and Truncation

Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
Forward Primer
Reverse Primer
BT2857N 4959
FlankR
BT2857N 4959
GeneR
BT3158 4959 NF
BT3158 4959 CF

BT2857N D35A
5’-ACCCTGCCGTCTGCGCCGGATCT-3’
5’-CAGCAGATCCGGCGCAGACGGCA-3’
BT2857N D37A
5’-CGTCTGATCCGGCGCTGCTGTATGTT-3’
5’-AACATACAGCAGCGCCGGATCAGACG-3’
BT2857N D83A
5’-TACACCGTTGACGCCTCTGAAAACCG-3’
5’-CGGTTTTCAGAGGCGTCAACGGTGTA-3’
BT2857N R84A
5’-TACACCGTTGACGCCTCTGAAAACCGT-3’
5’-ACGGTTTTCAGAGGCGTCAACGGTGTA-3’
BT2857C D239A
5'-TTTTACCGTCGTAAGAGGCAACACGAGAGTCGTTC-3'
5'-GAACGACTCTCGTGTTGCCTCTTACGACGGTAAAA-3'
BT2857C D242A
5’-ATTTTACCGGCGTAAGAGTCAACACGA-3’
5’-GACTCTTACGCCGGTAAAATGGAATACGTT-3’
BT2857C H300A
5’-GGTACCGGTCGGCAGACCAACGCCA-3’
5’-GTTGGTCTGGCCACCGGTACCGGCA-3’
BT2857C D304A
5’-ATAACGACGCGGAGACATGGCGTTGTAGAA-3’
5’-TTCTACAACGCCATGTCTCCGCGTCGTTAT-3’
BT2857N-DUF4959 Truncation
5’-CCGCTCACAATTCCCCTATAGTGAGTCG-3’
5’-CTCGAGCGGAACAACTTCAACGATCTG-3’
BT3158-DUF4959 Truncation
5’-CATATGTGCGAAGATGTAGAAACTCATAAA-3’
5’-CTCGAGGGTACTATTTCGGTGATGATA-3’
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Appendix 5: Amino Acid Sequence Results for Mutant BT2857C and BT2857N Constructs
BT2857N
D37A - 5
BT2857N
R84A - 2
BT2857C
D239A - 4

MVKPIENDKDAPGTVQDVKTESLPGAVKFTYTLPSDPALLYVLAKYTNKTGKVMEFRSSFYTNSV
TVEGFGDTDTYKVELYTVDRSENRSQPQIVEVVPLTPPILSCYESLSMVSDFGGMTFEMDNKFKS
DLAIYVCTPDELGDMVLAETFYSAREEIVYSVRGYDAVPRRFGIFLQDKYGNETDTLFTELTPIY
ERELDKTLEHHHHHH
MVKPIENDKDAPGTVQDVKTESLPGAVKFTYTLPSDPDLLYVLAKYTNKTGKVMEFRSSFYTNSV
TVEGFGDTDTYKVELYTVDASENRSQPQIVEVVPLTPPILSCYESLSMVSDFGGMTFEMDNKFKS
DLAIYVCTPDELGDMVLAETFYSAREEIVYSVRGYDAVPRRFGIFLQDKYGNETDTLFTELTPIY
ERELDKTLEHHHHHH
MELDKTKFREMYLQNDSRVASYDGKMEYVWNGRISKDGDSGGVGLHTGTGTKDGPAVFTFDLGVL
AKLSRFALWAIQDEKHFYNDMSPRRYEVWGCATEPNPDGSWDQWVKLLDMENVKPSGSPIGILTE
DDIEAAKIGDQANVPLDMPRVRYIRIKCLKNWSNNYNICFTELTFWGNDLEHHHHHH
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Appendix 6: pET21b(+) Vector with XhoI and NdeI Cut Sites Labelled to Insertion of Truncated
BT2857 and BT3158 Constructs
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Appendix 7: Crystal Diffraction Preliminary Statistics for Each Protein Construct
BT2857C
Statistic
Resolution (Å)
Space Group
Unit Cell Dimensions: a, b,
c, (β)
Measured Reflections
Unique Reflections
Multiplicity
Completeness (%)
Mosaicity
Rmerge
I/σ(I)
CC1/2(%)
BT3158
Statistic
Resolution (Å)
Space Group
Unit Cell Dimensions: a, b,
c, (β)
Measured Reflections
Unique Reflections
Multiplicity
Completeness (%)
Mosaicity
Rmerge
I/σ(I)
CC1/2(%)

BT2857C 3-7
46.69 – 1.45 (1.53 – 1.45)
P21

BT2857Clacb3
46.87 – 1.45 (1.53 – 1.45)
P21

59.14, 60.94, 61.63 (101.39)

59.30, 61.08, 61.76 (101.59)

501995 (50476)
74234 (9268)
5.4 (3.9)
99.3 (85)
0.39
2.3 (6.5)
24.1 (16.0)
1.000 (0.995)

495287 (67903)
76475 (11085)
6.5 (6.1)
99.9 (97.6)
0.12
10.2 (28.1)
11.4 (4.7)
0.997 (0.967)

BT3158 7-8
46.96 – 1.53 (1.61 – 1.53)
C121

BT3158GAL_01
40.66 – 1.80 (1.90 – 1.80)
C121

59.14, 60.94, 61.63 (101.39)

75.14, 48.96, 113.22 (103.76)

424568 (50476)
64687 (9268)
6.6 (5.4)
99.8 (98.8)
0.39
0.025 (0.058)
50.1 (24.1)
1.000 (0.997)

138416 (19994)
37206 (5362)
3.7 (3.7)
99.8 (99.9)
0.44
0.72 (0.389)
11.1 (3.2)
0.996 (0.869)
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BT3158-SelenoMet
Statistic
Resolution (Å)
Space Group
Unit Cell Dimensions: a, b,
c, (β)
Measured Reflections
Unique Reflections
Multiplicity
Completeness (%)
Mosaicity
Rmerge
I/σ(I)
CC1/2(%)

BT3158 7-16
40.27 – 2.01 (2.12 – 2.01)
C121
76.18, 49.12, 115.21, (105.03)
102912 (15076)
27426 (3967)
3.8 (3.8)
99.3 (98.9)
0.29
0.053 (0.270)
15.9 (5.0)
0.999 (0.944)

PGN1176 Screening Summary
Resolution (Å)
Space Group
Unit Cell Dimensions: a, b,
c, (β)
Multiplicity
Completeness (%)
Mosaicity
I/σ(I)

Pgn1176 6-8
6.7
P1

Pgn1176 6-9
6.8
P1

149.00, 158.42, 158.42, (90)

152.54, 161.55, 161.89 (90)

2.0
99.5
0.32
0.0

2.0
99.5
0.30
0.1

Pgn1461 4-7
47.99 - 2.10 (2.21 – 2.10)
P212121

Pgn1461 4-5
47.99 – 2.16 (2.28 – 2.16)
P212121

122.13, 128.20, 171.39 (90)

122.07, 128.07, 171.10 (90)

2064190 (280695)
156796 (22686)
13.2 (12.4)
99.9 (100.0)
0.13
0.259 (1.062)
9.1 (2.4)
0.999 (0.903)

1917127 (281916)
144252 (20851)
13.3 (13.5)
99.9 (100.0)
0.16
0.234 (0.840)
9.7 (3.2)
0.996 (0.943)

PGN1461
Resolution (Å)
Space Group
Unit Cell Dimensions: a, b,
c, (β)
Measured Reflections
Unique Reflections
Multiplicity
Completeness (%)
Mosaicity
Rmerge
I/σ(I)
CC1/2 (%)
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